EurekaMag Full Text Articles Chapter 9,067

Yarema, K.J.; Lippard, S.J.; Essigmann, J.M. 1995: Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II). Nucleic Acids Research 23(20): 4066-4072

Roldán-Arjona, T.; Pueyo, C. 1993: Mutagenic and lethal effects of halogenated methanes in the Ara test of Salmonella typhimurium: Quantitative relationship with chemical reactivity. Mutagenesis 8(2): 127-131

Yahiaoui, R.; Guechi, A.; Lukasova, E.; Girre, L. 1994: Mutagenic and membranal effect of a phytotoxic molecule isolated from olive leaves parasitized by the fungus Cycloconium oleaginum Cast. Mycopathologia 126(2): 121-129

Korah, R.M.; Humayun, M.Z. 1993: Mutagenic and recombinagenic effects of diethylstilbestrol quinone. Mutation Research 289(2): 205-214

Saab-Rincón, G.; Gualfetti, P.J.; Matthews, C.R. 1996: Mutagenic and thermodynamic analyses of residual structure in the alpha subunit of tryptophan synthase. Biochemistry 35(6): 1988-1994

Gilli, G.; Carraro, E.; Lorenzatti, G.; Fea, E.; Natale, P. 1994: Mutagenic characteristics of airborne particulate matter in an industrial town in north Italy. Igiene Moderna 101(6): 723-738

Mcgregor, D. 1998: Mutagenic chemicals: Their significance. Biotherapy 11(2-3): 169-180

Uribe-Luna, S.; Quintana-Hau, J.D.; Maldonado-Rodriguez, R.; Espinosa-Lara, M.; Beattie, K.L.; Farquhar, D.; Nelson, J.A. 1997: Mutagenic consequences of the incorporation of 6-thioguanine into DNA. Biochemical Pharmacology 54(3): 419-424

Sanderson, B.J.; Shield, A.J. 1996: Mutagenic damage to mammalian cells by therapeutic alkylating agents. Mutation Research 355(1-2): 41-57

Turner, G.J.; Galacteros, F.; Doyle, M.L.; Hedlund, B.; Pettigrew, D.W.; Turner, B.W.; Smith, F.R.; Moo-Penn, W.; Rucknagel, D.L.; Ackers, G.K. 1992: Mutagenic dissection of hemoglobin cooperativity: effects of amino acid alteration on subunit assembly of oxy and deoxy tetramers. Proteins 14(3): 333-350

Kil'kichko, A.A.; Furman, M.A.; Glavin, A.A.; Rubenchik, B.L. 1993: Mutagenic effect of N-nitrosodimethylamine synthesis precursors in Ames test. Eksperimental'naya Onkologiya 15(6): 25-28

Frank, V.; Támová, G. 1993: Mutagenic effect of cadmium on Trichoderma viride. Acta Microbiologica Hungarica 40(1): 65-69

Broman, D.; Näf, C.; Rannug, U. 1994: Mutagenic effect of extracts from particulate matter collected with sediment traps in the archipelago of Stockholm and the open northern Baltic. Bulletin of Environmental Contamination and Toxicology 53(5): 669-674

Gavrila, L.; Timus, D.; Lungeanu, A.; Mocanu, N.; Ghetea, L.; Mihaescu, G.; Ionescu, D.M.rcea 1994: Mutagenic effect of gamma and beta ionizing radiation on genetic material in plants and animals. Analele Universitatii Bucuresti Biologie 43: 51-66

Ariza, M.E.; Holliday, J.; Williams, M.V. 1994: Mutagenic effect of mercury (II) in eukaryotic cells. In Vivo 8(4): 559-563

Shandala, T.V.; Peskova, A.A. 1993: Mutagenic effect of plasmid DNA pUC19 and its derivatives. Tsitologiya i Genetika 27(4): 40-43

Rubashevskii, E.L.; Patskovskii, Y.V.; Lysenko, E.F.; Kirilenko, S.D.; Lukash, L.L. 1993: Mutagenic effect of the pBR322ins recombinant plasmid carrying a native and modified human insulin gene. Tsitologiya i Genetika 27(4): 44-51

Reddy, S.K.; Rao, A.M. Mohan; Farook, S.A. 1993: Mutagenic effectiveness and efficiency of SA, dES and gamma rays on Helianthus annuus L. Asian Journal of Plant Science 5(1): 51-55

Zeerak, N.A. 1992: Mutagenic effectiveness and efficiency of gamma rays and ethyl methanesulphonate in Brinjal. Journal of Nuclear Agriculture and Biology 21(2): 84-87

Kinashi, Y.; Masunaga, S.; Takagaki, M.; Ono, K. 1997: Mutagenic effects at HPRT locus induced in Chinese hamster ovary cells by thermal neutrons with or without boron compound. Mutation Research 377(2): 211-215

Ogheri, S.; Rampazzo, C.; Celotti, L. 1995: Mutagenic effects at hprt locus and in minisatellite sequences induced in V79 cells by treatments with UV and methyl-nitro-nitroso guanidine. Mutation Research 348(4): 193-199

Grishanin, A.K.; Stepanova, V.A.; Pavlov, D.F.; Chuiko, G.M. 1993: Mutagenic effects of DDVP, cadmium and naphthalene in the erythrocytes of Mozambique tilapia: Micronuclei evaluations. Genetika 29(7): 1213-1217

Hei, T.K.; Wu, L.J.; Liu, S.X.; Vannais, D.; Waldren, C.A.; Randers-Pehrson, G.; Waldren, C.A. 1997: Mutagenic effects of a single and an exact number of alpha particles in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 94(8): 3765-3770

Barilyak, I.R.; Berdyshev, G.D.; Dugan, A.M. 1996: Mutagenic effects of apiculture products. Tsitologiya i Genetika 30(6): 48-55

Chen, S.Q.; Xue, K.X.; Wu, J.Z.; Ma, G.J. 1995: Mutagenic effects of bimolane. Zhongguo Yao Li Xue Bao 16(6): 531-533

Chauhan, S.P.; Patra, N.K. 1993: Mutagenic effects of combined and single doses of gamma rays and EMS in opium poppy. Plant Breeding 110(4): 342-345

Ansari, M.Y.K.; Siddiqui, S., A. 1995: Mutagenic effects of ethyl methane sulphonate on Ammi majus L. I. morphological variations, mutation frequency and yield. Phytomorphology (Delhi) 45(1-2): 23-29

Khrapunov, S.N.; Dragan, A.I. 1996: Mutagenic effects of laser radiation. Tsitologiya i Genetika 30(1): 58-65

Katoh, Y.; Maekawa, M.; Sano, Y. 1994: Mutagenic effects of nitropyrenes in a soybean test system. Mutation Research 320(1-2): 59-68

Kinashi, Y.; Nagasawa, H.; Little, J.B. 1993: Mutagenic effects of restriction enzymes in Chinese hamster cells: Evidence for high mutagenicity of Sau3AI at the hprt locus. Mutation Research 285(2): 251-257

Hendrich, C.; Siebert, W.E. 1997: Mutagenic effects of the excimer laser using a fibroblast transformation assay. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 13(2): 151-155

Garcia-Espana, A.; Kahn, J.M.; Saez, G.; Pellicer, A. 1996: Mutagenic effects of tumorigenic neutron radiation. International Journal of Cancer 65(5): 677-681

Ono, T.; Norimatsu, M.; Yoshimura, H. 1994: Mutagenic evaluation of primaquine, pentaquine and pamaquine in the Salmonella/mammalian microsome assay. Mutation Research 325(1): 7-10

Saribaş, A.S.; Schindler, J.F.; Viola, R.E. 1994: Mutagenic investigation of conserved functional amino acids in Escherichia coli L-aspartase. Journal of Biological Chemistry 269(9): 6313-6319

Little, J.; Vainio, H. 1994: Mutagenic lifestyles? A review of evidence of associations between germ-cell mutations in humans and smoking, alcohol consumption and use of 'recreational' drugs. Mutation Research 313(2-3): 131-151

Rosenkranz, H.S. 1996: Mutagenic nitroarenes, diesel emissions, particulate-induced mutations and cancer: An essay on cancer-causation by a moving target. Mutation Research 367(2): 65-72

Chen, W.; Lin, J.M.; Reinhart, L.; Weisburger, J.H. 1993: Mutagenic peroxides in diethyl ether. Mutation Research 287(2): 227-233

Moriya, M.; Zhang, W.; Johnson, F.; Grollman, A.P. 1994: Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proceedings of the National Academy of Sciences of the United States of America 91(25): 11899-11903

Niphadkar, M.P.; Bagwe, A.N.; Bhisey, R.A. 1996: Mutagenic potential of Indian tobacco products. Mutagenesis 11(2): 151-154

Vijayaraghavan, M.; Nagarajan, B. 1994: Mutagenic potential of acute exposure to organophosphorus and organochlorine compounds. Mutation Research 321(1-2): 103-111

Singh, S.; Khanduja, K.L.; Mittal, P.K. 1997: Mutagenic potential of benzo(a)pyrene and N-nitrosodiethylamine is not affected by 50-Hz sinusoidal electromagnetic field. Electro and Magnetobiology 16(2): 169-175

Gupta, R.K.; Korte, D.W.; Reddy, G. 1993: Mutagenic potential of nitroguanidine and nitrosoguanidine in the Drosophila melanogaster sex-linked recessive lethal assay. Journal of Applied Toxicology: Jat 13(4): 231-234

Stea, S.; Savarino, L.; Ciapetti, G.; Cenni, E.; Stea, S.; Trotta, F.; Morozzi, G.; Pizzoferrato, A. 1994: Mutagenic potential of root canal sealers: evaluation through Ames testing. Journal of Biomedical Materials Research 28(3): 319-328

Manna, G.K.; Sadhukhan, G.C. 1993: Mutagenic potential of the non-nodulous nitrogen-fixing bacterium, Xanthobacter flavus in treated male parent mice and verified to their F-1 progeny. Cytologia 58(1): 9-19

Onodera, S.; Igarashi, K.; Fukuda, A.; Ouchi, J.; Suzuki, S. 1994: Mutagenic potentials of anthracene and phenanthrene compounds during water disinfection with chlorine. Japanese Journal of Toxicology and Environmental Health 40(3): 233-243

Fortini, P.; Calcagnile, A.; Vrieling, H.; van Zeeland, A.A.; Bignami, M.; Dogliotti, E. 1993: Mutagenic processing of ethylation damage in mammalian cells: the use of methoxyamine to study apurinic/apyrimidinic site-induced mutagenesis. Cancer Research 53(5): 1149-1155

Guillouf, C.; Laquerbe, A.; Moustacchi, E.; Papadopoulo, D. 1993: Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells. Mutagenesis 8(4): 355-361

Stock, S.; Esser, G.; Klockow, D.; Bolt, H.M.; Degen, G.H. 1998: Mutagenic properties of 1,2,3,4-tetrahydronaphthaline-1-hydroperoxide, a model compound for organic peroxides in Diesel exhaust. Archives of Toxicology 72(6): 342-346

Horsfall, M.J.; Borden, A.; Lawrence, C.W. 1997: Mutagenic properties of the T-C cyclobutane dimer. Journal of Bacteriology 179(9): 2835-2839

Baguley, B.C.; Ferguson, L.R. 1998: Mutagenic properties of topoisomerase-targeted drugs. Biochimica Et Biophysica Acta 1400(1-3): 213-222

Thomas, D.C.; Veaute, X.; Kunkel, T.A.; Fuchs, R.P. 1994: Mutagenic replication in human cell extracts of DNA containing site-specific N-2-acetylaminofluorene adducts. Proceedings of the National Academy of Sciences of the United States of America 91(16): 7752-7756

Studzian, K.; Telleman, P.; van der Schans, G.P.; Zdzienicka, M.Z. 1994: Mutagenic response and repair of cis-DDP-induced DNA cross-links in the Chinese hamster V79 cell mutant V-H4 which is homologous to Fanconi anemia (group A). Mutation Research 314(2): 115-120

Kargacin, B.; Klein, C.B.; Costa, M. 1993: Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus. Mutation Research 300(1): 63-72

Sardaş, S.; Karahalil, B.; Karakaya, A.E.; Saşmaz, R. 1994: Mutagenic risk in psoriatic patients before and after 8-methoxypsoralen and long-wave ultraviolet radiation. Mutation Research 312(2): 79-83

Lyngdoh, R.H.Duncan 1994: Mutagenic role of Watson-Crick protons in alkylated DNA bases: A theoretical study. Journal of Biosciences 19(2): 131-143

Shibutani, S.; Suzuki, N.; Grollman, A.P. 1998: Mutagenic specificity of (acetylamino)fluorene-derived DNA adducts in mammalian cells. Biochemistry 37(35): 12034-12041

Terashima, I.; Suzuki, N.; Itoh, S.; Yoshizawa, I.; Shibutani, S. 1998: Mutagenic specificity of model estrogen-DNA adducts in mammalian cells. Biochemistry 37(24): 8803-8807

Shcherbakova, P.V.; Pavlov, Y.I. 1993: Mutagenic specificity of the base analog 6-N-hydroxylaminopurine in the URA3 gene of the yeast Saccharomyces cerevisiae. Mutagenesis 8(5): 417-421

Kitamura, K.; Yamamoto, K. 1996: Mutagenic specificity of ultraviolet light in the tonB gene on the chromosome of Escherichia coli uvrA cells. Biochemical and Biophysical Research Communications 220(3): 496-501

Macaulay, S.L.; Polites, M.; Frenkel, M.J.; Hewish, D.R.; Ward, C.W. 1995: Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor. Biochemical Journal 306: 811-820

Shapiro, M.J.; Koshland, D.E. 1994: Mutagenic studies of the interaction between the aspartate receptor and methyltransferase from Escherichia coli. Journal of Biological Chemistry 269(15): 11054-11059

Lacey, S.F.; Larder, B.A. 1994: Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance. Journal of Virology 68(5): 3421-3424

Shima, N.; Ichikawa, S. 1995: Mutagenic synergism detected between dimethyl sulfate and X-rays but not found between N-methyl-N-nitrosourea and X-rays in the stamen hairs of Tradescantia clone BNL 4430. Mutation Research 331(1): 79-87

Wagner, E.D.; Repetny, K.; Tan, J.S.; Gichner, T.; Plewa, M.J. 1997: Mutagenic synergy between paraoxon and mammalian or plant-activated aromatic amines. Environmental and Molecular Mutagenesis 30(3): 312-320

Gichner, T.; Veleminský, J.; Wagner, E.D.; Plewa, M.J. 1996: Mutagenic synergy between paraoxon and plant-activated m-phenylenediamine or 2-acetoxyacetylaminofluorene. Environmental and Molecular Mutagenesis 27(1): 59-66

George, J.; Kuttan, R. 1997: Mutagenic, carcinogenic and cocarcinogenic activity of cashewnut shell liquid. Cancer Letters 112(1): 11-16

Rust, S.; Funke, H.; Assmann, G. 1993: Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection. Nucleic Acids Research 21(16): 3623-3629

Kusamran, W.R.; Wakabayashi, K.; Oguri, A.; Tepsuwan, A.; Nagao, M.; Sugimura, T. 1994: Mutagenicities of Bangkok and Tokyo river waters. Mutation Research 325(2-3): 99-104

Herzog, R.; Leuschner, J. 1994: Mutagenicity studies of benzalazine. Arzneimittel-Forschung 44(12): 1366-1368

Liu, Y.; Gao, H.; Zhong, B.; Whong, W.Z.; Ong, T.M. 1993: Mutagenicity study of eight diesel emission samples. Hua Xi Yi Ke Da Xue Xue Bao 24(4): 442-445

Cheung, Y.L.; Puddicombe, S.M.; Gray, T.J.; Ioannides, C. 1994: Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity. Carcinogenesis 15(6): 1257-1263

Ozaki, A.; Kitano, M.; Itoh, N.; Kuroda, K.; Furusawa, N.; Masuda, T.; Yamaguchi, H. 1998: Mutagenicity and DNA-damaging activity of decomposed products of food colours under UV irradiation. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 36(9-10): 811-817

Miettinen, I.T.; Martikainen, P.J.; Vartiainen, T. 1998: Mutagenicity and amount of chloroform after chlorination of bank filtered lake water. Science of the Total Environment 215(1-2): 9-17

Zhao, Z.; Zhang, L.; Wei, L. 1995: Mutagenicity and anti-mutagenicity assay of airborne suspended particles in Shijiazhuang city. Zhonghua Yu Fang Yi Xue Za Zhi 29(4): 213-215

Soudamini, K.K.; Unnikrishnan, M.C.; Sukumaran, K.; Kuttan, R. 1995: Mutagenicity and anti-mutagenicity of selected spices. Indian Journal of Physiology and Pharmacology 39(4): 347-353

Higashimoto, M.; Purintrapiban, J.; Kataoka, K.; Kinouchi, T.; Vinitketkumnuen, U.; Akimoto, S.; Matsumoto, H.; Ohnishi, Y. 1993: Mutagenicity and antimutagenicity of extracts of three spices and a medicinal plant in Thailand. Mutation Research 303(3): 135-142

Chulasiri, M.; Bunyapraphatsara, N.; Moongkarndi, P. 1992: Mutagenicity and antimutagenicity of hispidulin and hortensin, the flavonoids from Millingtonia hortensis L. Environmental and Molecular Mutagenesis 20(4): 307-312

Hu, Y.; Liu, Y.; Zhang, X.; Wang, G.; Zhou, G.; Jiang, Y.; Pang, D. 1997: Mutagenicity and carcinogenicity of nabumetone. Hua Xi Yi Ke da Xue Xue Bao 28(2): 174-178

Bronzetti, G.; Cini, M.; Paoli, M.; Ciacchini, G.; Giaconi, V.; Morichetti, E. 1997: Mutagenicity and chemical analysis of airborne particulate matter collected in Pisa. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 16(2-3): 147-156

Demarini, D.M.; Lemieux, P.M.; Ryan, J.V.; Brooks, L.R.; Williams, R.W. 1994: Mutagenicity and chemical analysis of emissions from the open burning of scrap rubber tires. Environmental Science and Technology 28(1): 136-141

Harrington-Brock, K.; Doerr, C.L.; Moore, M.M. 1995: Mutagenicity and clastogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in L5178Y/TK+/(-)-3.7.2C mouse lymphoma cells. Mutation Research 348(3): 105-110

Monarca, S.; Zanardini, A.; Feretti, D.; Falistocco, E.; Antonelli, P.; Resola, S.; Moretti, M.; Villarini, M.; Nardi, G. 1998: Mutagenicity and clastogenicity of gas stove emissions in bacterial and plant tests. Environmental and Molecular Mutagenesis 31(4): 402-408

Granella, M.; Ballarin, C.; Nardini, B.; Marchioro, M.; Clonfero, E. 1995: Mutagenicity and contents of polycyclic aromatic hydrocarbons in new high-viscosity naphthenic oils and used and recycled mineral oils. Mutation Research 343(2-3): 145-150

Clonfero, E.; Nardini, B.; Marchioro, M.; Bordin, A.; Gabbani, G. 1996: Mutagenicity and contents of polycyclic aromatic hydrocarbons in used and recycled motor oils. Mutation Research 368(3-4): 283-291

Chiewchanwit, T.; Au, W.W. 1995: Mutagenicity and cytotoxicity of 2-butoxyethanol and its metabolite, 2-butoxyacetaldehyde, in Chinese hamster ovary (CHO-AS52) cells. Mutation Research 334(3): 341-346

Ma, H.; An, J.; Hsie, A.W.; Au, W.W. 1993: Mutagenicity and cytotoxicity of 2-methoxyethanol and its metabolites in Chinese hamster cells (the CHO/HPRT and AS52/GPT assays). Mutation Research 298(3): 219-225

Hakura, A.; Mochida, H.; Tsutsui, Y.; Yamatsu, K. 1994: Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella tester strains. Chemical Research in Toxicology 7(4): 559-567

Wang, C.J.; Lin, Y.L.; Lin, J.K. 1994: Mutagenicity and cytotoxicity of nitropyrrole compounds derived from the reaction of 2-acetyl pyrrole with nitrite. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 32(9): 839-844

Sandhu, J.K.; Birnboim, H.C. 1997: Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line. Mutation Research 379(2): 241-252

Bradley, L.J.; Yarema, K.J.; Lippard, S.J.; Essigmann, J.M. 1993: Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry 32(3): 982-988

Yin, X.J.; Liu, J.Z.; Li, Y.S.; Kong, X.H.; Liu, H. 1994: Mutagenicity and induction of drug-metabolizing enzyme activity by LPG combustion particulates in rats. Biomedical and Environmental Sciences: Bes 7(4): 346-356

Shelton, M.L.; Demarini, D.M. 1995: Mutagenicity and mutation spectra of 2-acetylaminofluorene at frameshift and base-substitution alleles in four DNA repair backgrounds of salmonella. Mutation Research 327(1-2): 75-86

Recio, L.; Sisk, S.; Meyer, K.; Pluta, L.; Bond, J.A. 1996: Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice. Toxicology 113(1-3): 106-111

Yang, J.L.; Lin, J.G.; Hu, M.C.; Wu, C.W. 1993: Mutagenicity and mutational spectrum of N-methyl-N'-nitro-N-nitrosoguanidine in the hprt gene in G1-S and late S phase of diploid human fibroblasts. Cancer Research 53(12): 2865-2873

Ji, J.; Hoffmann, J.S.; Loeb, L. 1994: Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis. Nucleic Acids Research 22(1): 47-52

Chiang, T.A.; Wu, P.F.; Wang, L.F.; Lee, H.; Lee, C.H.; Ko, Y.C. 1997: Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutation Research 381(2): 157-161,. 28

Wang, D.; Kreutzer, D.A.; Essigmann, J.M. 1998: Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutation Research 400(1-2): 99-115

Chiou, C.C.; Yang, J.L. 1995: Mutagenicity and specific mutation spectrum induced by 8-methoxypsoralen plus a low dose of UVA in the hprt gene in diploid human fibroblasts. Carcinogenesis 16(6): 1357-1362

Rao, S.S.; Burnison, B.K.; Rokosh, D.A.; Taylor, C.M. 1994: Mutagenicity and toxicity assessment of pulp mill effluent. Chemosphere 28(10): 1859-1870

Fiorio, R.; Morichetti, E.; Vellosi, R.; Bronzetti, G. 1993: Mutagenicity and toxicity of electromagnetic fields. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 12(3): 139-142

Xiao, W.; Nowak, M.; Laferte, S.; Fontanie, T. 1996: Mutagenicity and toxicity of the DNA alkylation carcinogens 1,2-dimethylhydrazine and azoxymethane in Escherichia coli and Salmonella typhimurium. Mutagenesis 11(3): 241-245

Filipic, M. 1995: Mutagenicity and toxicity of water extracts from the Sora river area. Mutation Research 342(1-2): 1-8

Chung, K.T.; Murdock, C.A.; Stevens, S.E.; Li, Y.S.; Wei, C.I.; Huang, T.S.; Chou, M.W. 1995: Mutagenicity and toxicity studies of p-phenylenediamine and its derivatives. Toxicology Letters 81(1): 23-32

Meshram, G.P.; Malini, R.P.; Rao, K.M. 1992: Mutagenicity evaluation of riot control agent o-chlorobenzylidene malononitrile (CS) in the Ames Salmonella/microsome test. Journal of Applied Toxicology: Jat 12(5): 377-384

Hagman, M.; Loogna, P.; Danielsson, D.; Domellöf, L. 1997: Mutagenicity from neutrophils after challenge with Helicobacter pylori and bile. European Journal of Surgery 163(10): 753-759

Fink, S.P.; Reddy, G.R.; Marnett, L.J. 1997: Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. Proceedings of the National Academy of Sciences of the United States of America 94(16): 8652-8657

Jansson, K.; Hyttinen, J.M.; Niittykoski, M.; Mäki-Paakkanen, J. 1995: Mutagenicity in vitro of 3,4-dichloro-5-hydroxy-2(5H)-furanone (mucochloric acid), a chlorine disinfection by-product in drinking water. Environmental and Molecular Mutagenesis 25(4): 284-287

Candreva, E.C.; Keszenman, D.J.; Barrios, E.; Gelós, U.; Nunes, E. 1993: Mutagenicity induced by hyperthermia, hot mate infusion, and hot caffeine in Saccharomyces cerevisiae. Cancer Research 53(23): 5750-5753

Adler, I.D.; Cao, J.; Filser, J.G.; Gassner, P.; Kessler, W.; Kliesch, U.; Neuhäuser-Klaus, A.; Nüsse, M. 1994: Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutation Research 309(2): 307-314

Higashimoto, M.; Yamamoto, T.; Kinouchi, T.; Matsumoto, H.; Ohnishi, Y. 1996: Mutagenicity of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid treated with nitrite in the presence of alcohols. Mutation Research 367(1): 43-49

Song, X.O.; Lin, F.; Jiang, Y.C.; Liu, X.R.; Zhang, P.H.; Liu, Y.Q. 1997: Mutagenicity of 19 organophosphorus pesticides in Saccharomyces cerevisiae D61.M. Zhongguo Yaolixue Yu Dulixue Zazhi 11(4): 291-293

Maeng, S.H.; Yu, I.J. 1997: Mutagenicity of 2-bromopropane. Industrial Health 35(1): 87-95

Li, S.Q.; Liu, Y.Q.; Ni, Z.Y.; Song, X.O.; Liu, X.R.; Zhao, L. 1993: Mutagenicity of 24 organophosphorus, pesticides determined by 6 short-term tests. Zhongguo Yaolixue Yu Dulixue Zazhi 7(1): 73-77

Grúz, P.; Jurícek, M.; Zák, P.; Velemínský, J. 1993: Mutagenicity of 3-azido-1,2-propanediol and 9-(3-azido-2-hydroxypropyl)-adenine in repair deficient strains of Escherichia coli. Mutation Research 303(1): 1-9

Blahová, M.; Lahitová, N.; Sokolík, J. 1997: Mutagenicity of 4-nitroquinoline n-oxide after its complexation with copper (II) 2-chlorophenoxyacetate. Folia Microbiologica 42(4): 401-402

Jackson-Grusby, L.; Laird, P.W.; Magge, S.N.; Moeller, B.J.; Jaenisch, R. 1997: Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proceedings of the National Academy of Sciences of the United States of America 94(9): 4681-4685

Noskov, V.; Negishi, K.; Ono, A.; Matsuda, A.; Ono, B.; Hayatsu, H. 1994: Mutagenicity of 5-bromouracil and N6-hydroxyadenine studied by yeast oligonucleotide transformation assay. Mutation Research 308(1): 43-51

Matsubara, T.; Tsuji, T.; Miyama, A.; Yamaguchi, H.; Funabiki, T. 1995: Mutagenicity of bile and pancreatic juice from patients with pancreatico-biliary maljunction. Hepato-Gastroenterology 42(2): 113-116

Rahden-Staroń, I.; Peczyńska-Czoch, W.; Kaczmarek, L. 1994: Mutagenicity of carboline methyl derivatives in Salmonella. Acta Microbiologica Polonica 43(2): 247-250

Papoulias, D.M.; Buckler, D.R. 1996: Mutagenicity of Great Lakes sediments. Journal of Great Lakes Research 22(3): 591-601

Brooks, L.R.; Jacobson, R.W.; Warren, S.H.; Kohan, M.J.; Donnelly, K.C.; George, S.E. 1997: Mutagenicity of HPLC-fractionated urinary metabolites from 2,4,6-trinitrotoluene-treated Fischer 344 rats. Environmental and Molecular Mutagenesis 30(3): 298-302

Reid, T.M.; DeBord, D.G.; Cheever, K.L.; Savage, R.E. 1998: Mutagenicity of N-OH-MOCA (4-amino-4'-hydroxylamino-bis-3,3'-dichlorodiphenylmethane) and PBQ (2-phenyl-1,4-benzoquinone) in human lymphoblastoid cells. Toxicology Letters 95(3): 205-210

Le Page, F.; Margot, A.; Grollman, A.P.; Sarasin, A.; Gentil, A. 1995: Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. Carcinogenesis 16(11): 2779-2784

Gentil, A.; Cabral-Neto, J.B.; Mariage-Samson, R.; Margot, A.; Imbach, J.L.; Rayner, B.; Sarasin, A. 1992: Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells. Journal of Molecular Biology 227(4): 981-984

Gentil, A.; Le Page, F.; Margot, A.; Lawrence, C.W.; Borden, A.; Sarasin, A. 1996: Mutagenicity of a unique thymine-thymine dimer or thymine-thymine pyrimidine pyrimidone (6-4) photoproduct in mammalian cells. Nucleic Acids Research 24(10): 1837-1840

Hoffman, G.R.; Deschênes, S.M.; Manyin, T.; Fuchs, R.P. 1996: Mutagenicity of acridines in a reversion assay based on tetracycline resistance in plasmid pBR322 in Escherichia coli. Mutation Research 351(1): 33-43

Shibuya, N.; Ohta, T.; Nakadaira, H.; Mano, H.; Endoh, K.; Yamamoto, M. 1993: Mutagenicity of activated carbon adsorbate of drinking water in the Ames assay. Tohoku Journal of Experimental Medicine 171(1): 89-95

Sato, M.I.; Valent, G.U.; Coimbrão, C.A.; Coelho, M.C.; Sanchez Sanchez, P.; Alonso, C.D.; Martins, M.T. 1995: Mutagenicity of airborne particulate organic material from urban and industrial areas of São Paulo, Brazil. Mutation Research 335(3): 317-330

Lee, H.; Lin, T.L.; Shieh, R.L.; Bian, S.S. 1994: Mutagenicity of airborne particulates from combustion of electric cables in a waste metal retrieval area. Mutation Research 324(1-2): 77-84

Sideropoulos, A.S.; Specht, S. 1994: Mutagenicity of airborne particulates in Allegheny County: unmasking of potential carcinogenicity by size class fractionation. Microbios 77(312): 167-179

Yamaguchi, T.; Yamazaki, H.; Yamauchi, A.; Kakiuchi, Y. 1994: Mutagenicity of airborne particulates in a roadside atmosphere. Japanese Journal of Toxicology and Environmental Health 40(6): 542-549

Matsumura, Y.; Shiozawa, T.; Matsushita, H.; Terao, Y. 1995: Mutagenicity of alkyl azides. Biological and Pharmaceutical Bulletin 18(12): 1805-1807

Matsushita, H.; Endo, O.; Matsushita, H.; Yamamoto, M.; Mochizuki, M. 1993: Mutagenicity of alkylhydrazine oxalates in Salmonella typhimurium TA100 and TA102 demonstrated by modifying the growth conditions of the bacteria. Mutation Research 301(4): 213-222

Kami, H.; Watanabe, T.; Hirayama, T. 1997: Mutagenicity of an ozonized solution of phenylendiamine derivatives in the Salmonella test. Japanese Journal of Toxicology and Environmental Health 43(6): 359-365

Kuboyama, N.; Fujii, A. 1992: Mutagenicity of analgesics, their derivatives, and anti-inflammatory drugs with S-9 mix of several animal species. Journal of Nihon University School of Dentistry 34(3): 183-195

Witt, K.L.; Bishop, J.B. 1996: Mutagenicity of anticancer drugs in mammalian germ cells. Mutation Research 355(1-2): 209-234

Ferguson, L.R.; Baguley, B.C. 1996: Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes. Mutation Research 355(1-2): 91-101

Devi, K.Rudrama 1994: Mutagenicity of antihelmintic drugs in mammals. 3. Effect of levamisole on germ cells of mice. Agricultural and Biological Research 10(1-2): 43-47

Götzl, E.; Schimmer, O. 1993: Mutagenicity of aristolochic acids (I, II) and aristolic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 8(1): 17-22

Hei, T.K.; Liu, S.X.; Waldren, C.; Waldren, C.A. 1998: Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 95(14): 8103-8107

Hakura, A.; Mochida, H.; Tsutsui, Y.; Yamatsu, K. 1995: Mutagenicity of benzoquinones for Ames Salmonella tester strains. Mutation Research 347(1): 37-43

Dubinina, L.G. 1995: Mutagenicity of bleomycin and cross-adaptation with alkylating agents in Crepis capillaris. Genetika 31(5): 652-659

Mano, H.; Yamamoto, M.; Araya, J.C.; Kato, K.; Tsutsui, M.; Ohta, T.; Yoshida, K.; Kinebuchi, H.; Hayatsu, H. 1993: Mutagenicity of blue rayon extracts of human bile in the Ames test. Mutation Research 290(2): 303-309

Cochrane, J.E.; Skopek, T.R. 1994: Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15(4): 713-717

Cochrane, J.E.; Skopek, T.R. 1994: Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15(4): 719-723

Kolar, C.; Lawson, T. 1997: Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells. Cancer Letters 117(2): 149-154

Zeiger, E. 1993: Mutagenicity of chemicals added to foods. Mutation Research 290(1): 53-61

Murakami, K.; Kinouchi, T.; Matsumoto, H.; Ohnishi, Y. 1996: Mutagenicity of chemicals produced from sodium dodecylbenzenesulfonate by treatment with ozone and ultraviolet irradiation. Tokushima Journal of Experimental Medicine 43(1-2): 47-54

Ohkubo, T.; Hayashi, T.; Watanabe, E.; Endo, H.; Goto, S.; Endo, O.; Mizoguchi, T.; Mori, Y. 1995: Mutagenicity of chlorohydrins. Nippon Suisan Gakkaishi 61(4): 596-601

Cheung, Y.L.; Gray, T.J.; Ioannides, C. 1993: Mutagenicity of chrysene, its methyl and benzo derivatives, and their interactions with cytochromes P-450 and the Ah-receptor; relevance to their carcinogenic potency. Toxicology 81(1): 69-86

El Nahas, S.M.; Samad, M.F.; de Hondt, H.A. 1997: Mutagenicity of cidial (phenthoate). I: Effect on maternal and fetal somatic cells. Environmental and Molecular Mutagenesis 29(1): 53-57

Stamm, S.C.; Zhong, B.Z.; Whong, W.Z.; Ong, T. 1994: Mutagenicity of coal-dust and smokeless-tobacco extracts in Salmonella typhimurium strains with differing levels of O-acetyltransferase activities. Mutation Research 321(4): 253-264

Kitahara, J.; Yamanaka, K.; Kato, K.; Lee, Y.W.; Klein, C.B.; Costa, M. 1996: Mutagenicity of cobalt and reactive oxygen producers. Mutation Research 370(3-4): 133-140

Morita, T.; Naitou, H.; Oishi, E. 1995: Mutagenicity of condensed pyridazines with different substituents. Biological and Pharmaceutical Bulletin 18(2): 363-367

Connor, T.H.; Tee, P.G.; Afshar, M.; Connor, K.M. 1996: Mutagenicity of cosmetic products containing Kathon. Environmental and Molecular Mutagenesis 28(2): 127-132

Sandnes, D.; Johansen, T.; Teien, G.; Ulsaker, G. 1992: Mutagenicity of crude senna and senna glycosides in Salmonella typhimurium. Pharmacology and Toxicology 71(3 Pt 1): 165-172

Busby, W.F.; Smith, H.; Plummer, E.F.; Lafleur, A.L.; Mulder, P.P.; Boere, B.B.; Cornelisse, J.; Lugtenburg, J. 1997: Mutagenicity of cyclopenta-fused polynuclear aromatic hydrocarbons and a non-polar fraction from a fuel combustion sample in a Salmonella forward mutation assay without exogenous metabolic activation. Mutation Research 391(3): 117-125

Schweikl, H.; Schmalz, G.; Bey, B. 1994: Mutagenicity of dentin bonding agents. Journal of Biomedical Materials Research 28(9): 1061-1067

Gautam, M.; Nussear, D.L.; Hong Guang, G.; Clark, N.N. 1993: Mutagenicity of diesel exhaust particulate matter in mining operations. Journal of Environmental Science and Health Part A Environmental Science and Engineering 28(3): 505-523

Hakura, A.; Tsutsui, Y.; Mochida, H.; Sugihara, Y.; Mikami, T.; Sagami, F. 1996: Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains. Mutation Research 371(3-4): 293-299

Patterson, K.S.; LykinsB.W.Jr; Richardson, S.D. 1995: Mutagenicity of drinking water following disinfection. Aqua (London) 44(1): 1-9

Parashari, A.; Singh, V.; Gupta, M.M.; Satyanararayana, L.; Chattopadhya, D.; Sehgal, A. 1996: Mutagenicity of endocervical mucus associated with genital tract infections. Cancer Detection and Prevention 20(6): 597-600

Alzuet, P.R.; Gaspes, E.; Ronco, A.E. 1996: Mutagenicity of environmental samples from and industrialized area of the Rio de la Plata estuary using the Salmonella/microsomal assay. Environmental Toxicology and Water Quality 11(3): 231-236

Parisis, D.M.; Eskoz, N.L.; Henderson, W.G. 1994: Mutagenicity of ethanolic extracts of used acrylic dentures. Mutation Research 321(4): 241-251

Williams, C.V.; Fletcher, K.; Tinwell, H.; Ashby, J. 1998: Mutagenicity of ethyl carbamate to lacZ- transgenic mice. Mutagenesis 13(2): 133-137

Hoflack, J.C.; Lambolez, L.; Elias, Z.; Vasseur, P. 1995: Mutagenicity of ethylene glycol ethers and of their metabolites in Salmonella typhimurium his-. Mutation Research 341(4): 281-287

Monarca, S.; Zanardini, A.; Feretti, D.; Dalmiglio, A.; Falistocco, E.; Manica, P.; Nardi, G. 1998: Mutagenicity of extracts of lake drinking water treated with different disinfectants in bacterial and plant tests. Water Research 32(9): 2689-2695,.

Grafström, R.C.; Hsu, I.C.; Harris, C.C. 1993: Mutagenicity of formaldehyde in Chinese hamster lung fibroblasts: Synergy with ionizing radiation and N-nitroso-N-methylurea. Chemico-Biological Interactions 86(1): 41-49

Voutsinas, G.; Kappas, A.; Demopoulos, N.A.; Camoutsis, C. 1993: Mutagenicity of four homo-aza-steroidal esters of m-N,N-bis(2-chloroethyl)aminocinnamic acid in the Ames test. Mutation Research 319(4): 325-329

Khan, Q.A.; Shamsi, F.A.; Hadi, S.M. 1995: Mutagenicity of furfural in plasmid DNA. Cancer Letters 89(1): 95-99

Dugan, A.M. 1998: Mutagenicity of gas component of atmospheric air as the index of its quality. Tsitologiya i Genetika 32(1): 108-116

Maragos, C.M.; Andrews, A.W.; Keefer, L.K.; Elespuru, R.K. 1993: Mutagenicity of glyceryl trinitrate (nitroglycerin) in Salmonella typhimurium. Mutation Research 298(3): 187-195

Lawson, T.; Kolar, C. 1994: Mutagenicity of heterocyclic amines when activated by pancreas tissue. Mutation Research 325(4): 125-128

McQueen, C.A.; Way, B.M.; Queener, S.M. 1993: Mutagenicity of hydralazine in mammalian cells and bacteria. Toxicology and Applied Pharmacology 118(1): 135-138

Hayashi, T.; Ren, H.; Taguchi, S.; Goto, S.; Endo, H.; Watanabe, E. 1998: Mutagenicity of hydrolyzed proteins. Journal of the Food Hygienic Society of Japan 39(2): 67-71

Mirvish, S.S.; Williamson, J.; Babcook, D.; Chen, S.C. 1993: Mutagenicity of iso-butyl nitrite vapor in the Ames test and some relevant chemical properties, including the reaction of iso-butyl nitrite with phosphate. Environmental and Molecular Mutagenesis 21(3): 247-252

Ukawa-Ishikawa, S.; Sawada, A.; Kasuya, K.; Mochizuki, M. 1998: Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds. Mutation Research 412(1): 99-107

Silva, I.D.; Rodrigues, A.; Gaspar, J.; Maia, R.; Laires, A.; Rueff, J. 1996: Mutagenicity of kaempferol in V79 cells: the role of cytochromes P450. Teratogenesis Carcinogenesis and Mutagenesis 16(4): 229-241

Gille, J.J.; van Berkel, C.G.; Joenje, H. 1994: Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis 15(12): 2695-2699

Tao, K.S.; Urlando, C.; Heddle, J.A. 1993: Mutagenicity of methyl methanesulfonate (MMS) in vivo at the Dlb-1 native locus and a lacI transgene. Environmental and Molecular Mutagenesis 22(4): 293-296

Stamm, S.C.; Lan, W.; Zhong, B.Z.; Whong, W.Z.; Ong, T. 1994: Mutagenicity of mild gasification products in Salmonella typhimurium. Mutation Research 320(4): 261-271

Busby, W.F.; Smith, H.; Bishop, W.W.; Thilly, W.G. 1994: Mutagenicity of mono- and dinitropyrenes in the Salmonella typhimurium TM677 forward mutation assay. Mutation Research 322(4): 221-232

Schmutte, C.; Rideout, W.M.; Shen, J.C.; Jones, P.A. 1994: Mutagenicity of nitric oxide is not caused by deamination of cytosine or 5-methylcytosine in double-stranded DNA. Carcinogenesis 15(12): 2899-2903

André, V.; Boissart, C.; Sichel, F.; Gauduchon, P.; Le Talaër, J.Y.; Lancelot, J.C.; Robba, M.; Mercier, C.; Chemtob, S.; Raoult, E. 1995: Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. II. Ortho-aminonitro derivatives of 9H-carbazole. Mutation Research 345(1-2): 11-25

André, V.; Boissart, C.; Sichel, F.; Gauduchon, P.; Le Talaër, J.Y.; Lancelot, J.C.; Mercier, C.; Chemtob, S.; Raoult, E.; Tallec, A. 1997: Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. III. Methylated derivatives of 9H-carbazole. Mutation Research 389(2-3): 247-260

André, V.; Boissart, C.; Lechevrel, M.; Gauduchon, P.; Le Talaër, J.Y.; Lancelot, J.C.; Letois, B.; Saturnino, C.; Rault, S.; Robba, M. 1993: Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. I. Monosubstituted derivatives of 9H-carbazole. Mutation Research 299(1): 63-73

Juneja, T.R.; Bala, A.; Kumar, P.; Gupta, R.L. 1995: Mutagenicity of nitrobenzyl derivatives: Potential bioreductive anticancer agents. Mutation Research 348(3): 137-145

Watanabe, T.; Kohan, M.J.; Walsh, D.; Ball, L.M.; Demarini, D.M.; Lewtas, J. 1995: Mutagenicity of nitrodibenzopyranones in the Salmonella plate-incorporation and microsuspension assays. Mutation Research 345(1-2): 1-9

Sera, N.; Fukuhara, K.; Miyata, N.; Tokiwa, H. 1996: Mutagenicity of nitrophenanthrene derivatives for Salmonella typhimurium: Effects of nitroreductase and acetyltransferase. Mutation Research 349(1): 137-144

Gallez, B.; De Meester, C.; Debuyst, R.; Dejehet, F.; Dumont, P. 1992: Mutagenicity of nitroxyl compounds: structure-activity relationships. Toxicology Letters 63(1): 35-45

Adonis, M.; Gil, L. 1993: Mutagenicity of organic extracts from Santiago (Chile) airborne particulate matter. Mutation Research 292(1): 51-61

Kong, Z.M.; Yu, L.W.; Liu, Z.T.; Wu, Q.L.; Wang, L.S.; Kong, L.R.; Han, S.Q. 1996: Mutagenicity of organic pollutants and their active components in the Xi River water at Shenyang. Bulletin of Environmental Contamination and Toxicology 56(5): 803-808

Takeuchi, T.; Matsugo, S.; Morimoto, K. 1997: Mutagenicity of oxidative DNA damage in Chinese hamster V79 cells. Carcinogenesis 18(11): 2051-2055

Matsuda, H.; Hibino, M.; Sato, T.; Ose, Y.; Nagase, H.; Kito, H. 1993: Mutagenicity of ozonated and chlorinated humic substances. Journal of Environmental Science and Health Part A Environmental Science and Engineering 28(4): 821-837

Yoshida, R.; Oikawa, S.; Ogawa, Y.; Miyakoshi, Y.; Ooida, M.; Asanuma, K.; Shimizu, H. 1998: Mutagenicity of p-aminophenol in E. coli WP2uvrA/pKM101 and its relevance to oxidative DNA damage. Mutation Research 415(1-2): 139-150

Palmer, W.G.; Andrews, A.W.; Mellini, D.; Terra, J.A.; Hoffmann, F.J.; Hoke, S.H. 1994: Mutagenicity of particulate emissions from the M16 rifle: variation with particle size. Journal of Toxicology and Environmental Health 42(4): 423-433

Lee, H.; Wang, L.; Shih, J.F. 1995: Mutagenicity of particulates from the laboratory combustion of plastics. Mutation Research 346(3): 135-144

Heddle, J.A.; Shepson, P.B.; Gingerich, J.D.; So, K.W. 1993: Mutagenicity of peroxyacetyl nitrate (PAN) in vivo: Tests for somatic mutations and chromosomal aberrations. Environmental and Molecular Mutagenesis 21(1): 58-66

Evans, H.H.; Horng, M.F.; Ricanati, M.; Deahl, J.T.; Oleinick, N.L. 1997: Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines. Photochemistry and Photobiology 66(5): 690-696,.

Onodera, S.; Takahashi, M.; Ogawa, M.; Suzuki, S. 1995: Mutagenicity of polychlorophenoxyphenols (predioxins) and their photo-degradation products in aqueous solution. Japanese Journal of Toxicology and Environmental Health 41(3): 212-219

Zhou, W.; Ye, S.H. 1997: Mutagenicity of scooter exhaust particulate matter. Journal of Toxicology and Environmental Health 52(1): 35-44

Lee, Y.W.; Pons, C.; Tummolo, D.M.; Klein, C.B.; Rossman, T.G.; Christie, N.T. 1993: Mutagenicity of soluble and insoluble nickel compounds at the gpt locus in G12 Chinese hamster cells. Environmental and Molecular Mutagenesis 21(4): 365-371

Shahin, M.M. 1993: Mutagenicity of structurally related phenylazo-3-pyridines in Salmonella typhimurium. Cell Biology and Toxicology 9(1): 33-47

Spanggord, R.J.; Stewart, K.R.; Riccio, E.S. 1995: Mutagenicity of tetranitroazoxytoluenes: A preliminary screening in Salmonella typhimurium strains TA100 and TA100NR. Mutation Research 335(3): 207-211

Busby, W.F.; Smith, H.; Crespi, C.L.; Penman, B.W.; Lafleur, A.L. 1997: Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assays. Mutation Research 389(2-3): 261-270

Qian, D.; Kinouchi, T.; Kunitomo, K.; Kataoka, K.; Matin, M.A.; Akimoto, S.; Komi, N.; Ohnishi, Y. 1993: Mutagenicity of the bile of dogs with an experimental model of an anomalous arrangement of the pancreaticobiliary duct. Carcinogenesis 14(4): 743-747

Sera, N.; Tokiwa, H.; Miyata, N. 1996: Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 17(10): 2163-2169

Katayama, S. 1993: Mutagenicity of the gastric juice in chronic gastritis. Nihon Shokakibyo Gakkai Zasshi 90(7): 1547-1554

Fletcher, K.; Tinwell, H.; Ashby, J. 1998: Mutagenicity of the human bladder carcinogen 4-aminobiphenyl to the bladder of Muta Mouse transgenic mice. Mutation Research 400(1-2): 245-250

Zhu, S.; Zeiger, E. 1993: Mutagenicity of the human carcinogen treosulphan, and its hydrolysis product, dl-1,2:3,4-diepoxybutane in mammalian cells. Environmental and Molecular Mutagenesis 21(1): 95-99

Lefevre, P.A.; Tinwell, H.; Ashby, J. 1997: Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol. Mutagenesis 12(1): 45-47

Chang, R.L.; Wong, C.Q.; Kline, S.A.; Conney, A.H.; Goldstein, B.D.; Witz, G. 1994: Mutagenicity of trans,trans-muconaldehyde and its metabolites in V79 cells. Environmental and Molecular Mutagenesis 24(2): 112-115

Sjögren, M.; Sjöberg, U.; Rannug, U. 1994: Mutagenicity of tryptophan photoproducts in the ames Salmonella assay. Mutation Research 321(4): 229-239

Huang, J.; Li, H.; Gan, H.; Wu, K. 1998: Mutagenicity of typical organo-halogenated compounds from drinking water. Huanjing Kexue 19(1): 54-57

Sun, C.; Chen, B.; Wang, S. 1995: Mutagenicity of tyramine extracted from salted dried fish in high-risk area of gastric cancer in Zhuanghe county. Zhonghua Yu Fang Yi Xue Za Zhi 29(4): 205-208

Chiang, S.Y.; Swenberg, J.A.; Weisman, W.H.; Skopek, T.R. 1997: Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line. Carcinogenesis 18(1): 31-36

Nozaka, T.; Yamada, S.; Hirose, Y.; Ishino, M.; Tanaka, A. 1994: Mutagenicity screening of water extracts from crude drugs and quercetin as mutagenic component. Japanese Journal of Toxicology and Environmental Health 40(1): 66-70

Otsuka, M.; Kajiwara, Y.; Ajimi, S.; Shimazaki, H.; Kikuno, T.; Ogura, S.; Inai, T.; Kakimoto, K.; Tamura, H.; Watanabe, M.; Sumi, N. 1997: Mutagenicity studies of (racemic)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence. Journal of Toxicological Sciences 22(Suppl 1): 251-261

Tamura, H.; Yamashita, Y.; Kitayama, E.; Iwakura, K.; Watanabe, M.; Sumi, N. 1997: Mutagenicity studies of RCC-36, the active metabolite of (racemic)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence. Journal of Toxicological Sciences 22(Suppl 1): 263-274

Tanifuji, H.; Hisada, S.; Morihira, M.; Eguchi, K.; Kuwayama, N.; Horiuchi, T.; Suzuki, M., R.; Suzuki, O.; Kamogawa, S.; Terasoma, M. 1994: Mutagenicity studies of a potent antiandrogen, osaterone acetate (TZP-4238), on bacteria, cultured mammalian cells and mouse bone marrow. Pharmacometrics 47(3): 297-302

Igarashi, M.; Nakayama, S.; Jones, E.; Shimada, H. 1995: Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium. Journal of Toxicological Sciences 20(Suppl 1): 125-131

Iwakura, K.; Tamura, H.; Watanabe, M.; Sumi, N. 1994: Mutagenicity studies of lactitol (NS-4). Journal of Toxicological Sciences 19(Suppl): 487-497

Moriwaki, T.; Yamada, H.; Koga, T.; Nakajima, M.; Kitazawa, M.; Ugai, Y. 1995: Mutagenicity studies of lemildipine (NB-818) 9. Oyo Yakuri 50(3): 351-358

Iwakura, K.; Tamura, H.; Yamashita, Y.; Kitayama, E.; Hamasu, Y.; Nagasawa, H.; Watanabe, M.; Sumi, N. 1995: Mutagenicity studies of montirelin hydrate (NS-3). Journal of Toxicological Sciences 20(Suppl): 325-334

Saigo, K.; Hagiwara, T.; Ohnishi, M.; Nagata, R.; Nakamura, M.; Mizoguchi, T.; Yamakawa, H. 1997: Mutagenicity studies of omoconazole nitrate (HOC-155). Oyo Yakuri 53(6): 483-491

Nakamura, S.; Hayashi, T.; Nojima, Y.; Kizawa, K.; Tsuneda, R.; Kawamura, Y.; Kodama, T. 1998: Mutagenicity studies of osutidine (T-593), a novel antiulcer agent. Oyo Yakuri 55(5): 279-285

Otsuka, M.; Ajimi, S.; Kajiwara, Y.; Ogura, S.; Kakimoto, K.; Inai, T.; Tanaka, H.; Ohuchida, A. 1992: Mutagenicity studies of prednisolone farnesylate (PNF). Journal of Toxicological Sciences 17(Suppl): 269-281

Iwakura, K.; Tamura, H.; Yamashita, Y.; Watanabe, M.; Sumi, N.; Shindo, Y.; Ando, M.; Kojima, M. 1996: Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394). Journal of Toxicological Sciences 21(Suppl): 241-257

Kawamura, Y.; Saito, Y.; Imamura, M.; Modderman, J.P. 1996: Mutagenicity studies on erythritol in bacterial reversion assay systems and in Chinese hamster fibroblast cells. Regulatory Toxicology and Pharmacology: Rtp 24(2 Part 2): S261-S263

Kumari, J.; Krishnamurthy, N.B.; Vasudev, V. 1995: Mutagenicity studies with Metasystox-R in mice. Cell and Chromosome Research 18(2-3): 79-85

Ohuchida, A.; Kouchi, Y.; Sato, S.; Maeda, Y. 1996: Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo. Journal of Toxicological Sciences 21(Suppl 3): 675-689

Nakanishi, Y.ki; Ohnishi, Seido; Otaka, Tadahiko 1994: Mutagenicity study of fropenem sodium (SY5555). Pharmacometrics 47(2): 133-137

Nakanishi, Y.ki; Sugiyama, Kazushi; Ochiai, Tayehito 1997: Mutagenicity study of lanoteplase (genetical recombination). Oyo Yakuri 54(6): 335-339

Nagasawa, Y.; Miwa, Y.; Hongyo, T.; Sugawara, M.; Kawase, S. 1994: Mutagenicity study of mesalazine. Pharmacometrics 48(6): 501-509

Shindo, Y.; Hayashi, H.; Ando, M.; Tatebayashi, T. 1996: Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil. Arzneimittel-Forschung 46(8): 815-821

Shimada, H.; Hattori, C.; Tanaka, N.; Takayama, S. 1994: Mutagenicity study of the new cognition-enhancing agent nefiracetam. Arzneimittel-Forschung 44(2a): 251-253

Auletta, A.E.; Dearfield, K.L.; Cimino, M.C. 1993: Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs. Environmental and Molecular Mutagenesis 21(1): 38-45; Discussion 46-57

Ren, H.; Hayashi, T.; Ohkubo, T.; Goto, S.; Endo, H.; Watanabe, E. 1997: Mutagenicity test suitable for marine natural seasonings containing free histidine. Nippon Suisan Gakkaishi 63(1): 90-96

Jurado, J.; Alejandre-Durán, E.; Pueyo, C. 1994: Mutagenicity testing in Salmonella typhimurium strains possessing both the His reversion and Ara forward mutation systems and different levels of classical nitroreductase or O-acetyltransferase activities. Environmental and Molecular Mutagenesis 23(4): 286-293

Gomes-Carneiro, M.-Regina; Felzenszwalb, I.; Paumgartten, F., J.R. 1998: Mutagenicity testing of (racemic)-camphor, 1,8-cineole, citral, citronellal, (-)-menthol and terpineol with the Salmonella/microsome assay. Mutation Research 416(1-2): 129-136

Pal, B.B.; Bhunya, S.P. 1995: Mutagenicity testing of a rodenticide, zinctox (zinc phosphide) in a mouse in vivo system. In Vivo 9(1): 81-83

Forster, R.; Blowers, S.D.; Cinelli, S.; Marquardt, H.; Westendorf, J. 1992: Mutagenicity testing of imidazole and related compounds. Mutation Research 298(2): 71-79

Ostby, L.; Engen, S.; Melbye, A.; Eide, I. 1997: Mutagenicity testing of organic extracts of diesel exhaust particles after fractionation and recombination. Archives of Toxicology 71(5): 314-319

Kaur, A.; Singh, R.; Grover, I.S. 1993: Mutagenicity testing of textile (azo) dyes with Salmonella/microsome assay. Journal of Environmental Biology 14(4): 327-333

Hirai, O.; Miyamae, Y.; Zaizen, K.; Miyamoto, A.; Takashima, M.; Hattori, Y.; Ohara, K.; Mine, Y. 1994: Mutagenicity tests of polyoxyethylene hydrogenated castor oil 60 (HCO-60). Journal of Toxicological Sciences 19(2): 89-96

Ohuchida, A.; Taniguti, A.; Kouchi, Y.; Maeda, Y.; Kashihara, A.; Omae, S. 1994: Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin. Journal of Toxicological Sciences 19(Suppl): 263-280

Ashby, J.; Vogel, E.W.; Tinwell, H.; Callander, R.D.; Shuker, D.E. 1993: Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: Prediction of carcinogenic potency. Mutation Research 286(1): 101-109

Tinwell, H.; Yendle, J.; Ashby, J. 1996: Mutagenicity to the mouse bone marrow by the mouse germ cell mutagen N-propyl-N-nitrosourea. Mutation Research 370(3-4): 141-143

Léonard, A.; Gerber, G.B. 1996: Mutagenicity, carcinogenicity and teratogenicity of antimony compounds. Mutation Research 366(1): 1-8

Gerber, G.B.; Leonard, A. 1997: Mutagenicity, carcinogenicity and teratogenicity of germanium compounds. Mutation Research 387(3): 141-146,.

Léonard, A.; Hantson, P.; Gerber, G.B. 1995: Mutagenicity, carcinogenicity and teratogenicity of lithium compounds. Mutation Research 339(3): 131-137

Léonard, A.; Gerber, G.B. 1997: Mutagenicity, carcinogenicity and teratogenicity of thallium compounds. Mutation Research 387(1): 47-53

Léonard, A.; Gerber, G.B. 1994: Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutation Research 317(1): 81-88

Durnev, A.D. 1997: Mutagens and antimutagens in food products. Genetika 33(2): 165-176

Monarca, S.; Crebelli, R.; Feretti, D.; Zanardini, A.; Fuselli, S.; Filini, L.; Resola, S.; Bonardelli, P.G.; Nardi, G. 1997: Mutagens and carcinogens in size-classified air particulates of a Northern Italian town. Science of the Total Environment 205(2-3): 137-144

Shields, P.G.; Xu, G.X.; Blot, W.J.; Fraumeni, J.F.; Trivers, G.E.; Pellizzari, E.D.; Qu, Y.H.; Gao, Y.T.; Harris, C.C. 1995: Mutagens from heated Chinese and U.S. cooking oils. Journal of the National Cancer Institute 87(11): 836-841

Nardini, B.; Granella, M.; Clonfero, E. 1994: Mutagens in indoor air particulate. Mutation Research 322(3): 193-202

Nardini, B.; Clonfero, E. 1992: Mutagens in urban air particulate. Mutagenesis 7(6): 421-425

Brown, K.; Park, S.; Kanno, T.; Franzoso, G.; Siebenlist, U. 1993: Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proceedings of the National Academy of Sciences of the United States of America 90(6): 2532-2536

Ruiz, A.; Santos, M.; Soriano, P.J.; Cavelier, J.; Cadena, A. 1997: Mutalistic relations between the bat Glossophaga longirostris and the columnar cacti in the arid region of La Tatacoa, Colombia. Biotropica 29(4): 469-479

Köhler, B.; Bjarnason, S.; Care, R.; Mackevica, I.; Rence, I. 1995: Mutans streptococci and dental caries prevalence in a group of Latvian preschool children. European Journal of Oral Sciences 103(4): 264-266

Närhi, T.O.; Ainamo, A.; Meurman, J.H. 1994: Mutans streptococci and lactobacilli in the elderly. Scandinavian Journal of Dental Research 102(2): 97-102

Songpaisan, Y.; Serinirach, R.; Kuvatanasuchati, J.; Bratthall, D. 1994: Mutans streptococci in a Thai population: relation to caries and changes in prevalence after application of fissure sealants. Caries Research 28(3): 161-168

Matee, M.I.; Mikx, F.H.; de Soet, J.S.; Maselle, S.Y.; de Graaff, J.; van Palenstein Helderman, W.H. 1993: Mutans streptococci in caries-active and caries-free infants in Tanzania. Oral Microbiology and Immunology 8(5): 322-324

Kitamura, K.; Kiyoi, H.; Yoshida, H.; Saito, H.; Ohno, R.; Naoe, T. 1997: Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia. Leukemia 11(11): 1950-1956

Olkowski, Z.L. 1998: Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport 9(2): 239-242

Dieckmann, T.; Butcher, S.E.; Sassanfar, M.; Szostak, J.W.; Feigon, J. 1997: Mutant ATP-binding RNA aptamers reveal the structural basis for ligand binding. Journal of Molecular Biology 273(2): 467-478

Alix, J.H.; Guérin, M.F. 1993: Mutant DnaK chaperones cause ribosome assembly defects in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 90(20): 9725-9729

Burke, M.; Merican, A.F.; Sherratt, D.J. 1994: Mutant Escherichia coli arginine repressor proteins that fail to bind L-arginine, yet retain the ability to bind their normal DNA-binding sites. Molecular Microbiology 13(4): 609-618

Del Río, G.; Rodríguez, M.E.; Munguía, M.E.; López-Munguí, A.; Soberón, X. 1995: Mutant Escherichia coli penicillin acylase with enhanced stability at alkaline pH. Biotechnology and Bioengineering 48(2): 141-148

Hirano, M.; Tamaru, Y.; Ito, H.; Matsumoto, S.; Imai, T.; Ueno, S. 1996: Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset. Annals of Neurology 40(5): 796-798

Vilsen, B. 1995: Mutant Glu781 fwdarw Ala of the rat kidney Na+,K+-ATPase displays low cation affinity and catalyzes ATP hydrolysis at a high rate in the absence of potassium ions. Biochemistry 34(4): 1455-1463

Moore, J.; Boswell, S.; Hoffman, R.; Burgess, G.; Hromas, R. 1993: Mutant H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leukemia Research 17(8): 703-709

Fernandes, R.S.; McGowan, A.J.; Cotter, T.G. 1996: Mutant H-ras overexpression inhibits drug and U.V. induced apoptosis. Anticancer Research 16(4a): 1691-1705

Burgaud, J.L.; Resnicoff, M.; Baserga, R. 1995: Mutant IGF-i receptors as dominant negatives for growth and transformation. Biochemical and Biophysical Research Communications 214(2): 475-481

Cai, J.; Zhu, L.W.; Zhang, J.Y. 1997: Mutant K-ras and abnormal cytokinetics in rectal cancer. Zhongguo Zhongliu Linchuang 24(11): 823-826

Minamoto, T.; Yamashita, N.; Ochiai, A.; Mai, M.; Sugimura, T.; Ronai, Z.; Esumi, H. 1995: Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 75(6 Suppl): 1520-1526

Shepley, D.P.; Little, J.W. 1996: Mutant LexA proteins with specific defects in autodigestion. Proceedings of the National Academy of Sciences of the United States of America 93(21): 11528-11533

Tsai, L.C.; Bonander, N.; Harata, K.; Karlsson, G.; Vänngård, T.; Langer, V.; Sjölin, L. 1996: Mutant Met121Ala of Pseudomonas aeruginosa azurin and its azide derivative: crystal structures and spectral properties. Acta Crystallographica. Section D Biological Crystallography 52(Part 5): 950-958

Darley, R.L.; Hoy, T.G.; Baines, P.; Padua, R.A.; Burnett, A.K. 1997: Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells. Journal of Experimental Medicine 185(7): 1337-1347

Ciernik, I.F.; Berzofsky, J.; Carbone, D.P. 1995: Mutant oncopeptide immunization induces CTL specifically lysing tumor cells endogenously expressing the corresponding intact mutant p53. Hybridoma 14(2): 139-142

Arroyo, M.P.; Wang, T.S. 1998: Mutant PCNA alleles are associated with cdc phenotypes and sensitivity to DNA damage in fission yeast. Molecular and General Genetics: Mgg 257(5): 505-518

Gallagher, A.P.; Burnett, A.K.; Bowen, D.T.; Darley, R.L. 1998: Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process. Cancer Research 58(9): 2029-2035

Press, B.; Feng, Y.; Hoflack, B.; Wandinger-Ness, A. 1998: Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. Journal of Cell Biology 140(5): 1075-1089

Logan, K.M.; Skiba, M.C.; Eldin, S.; Knight, K.L. 1997: Mutant RecA proteins which form hexamer-sized oligomers. Journal of Molecular Biology 266(2): 306-316

Xing, X.; Matin, A.; Yu, D.; Xia, W.; Sorgi, F.; Huang, L.; Hung, M.C. 1996: Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Cancer Gene Therapy 3(3): 168-174

Rusakova, E.E.; Tunitskaya, V.L.; Memelova, L.V.; Kochetkova, S.V.; Kostyuk, D.A.; Kochetkov, S.N. 1998: Mutant T7 RNA polymerase is capable of catalyzing DNA primer extension reaction. Febs Letters 423(2): 189-192

Joseph, E.M.; Melton, D.A. 1998: Mutant Vg1 ligands disrupt endoderm and mesoderm formation in Xenopus embryos. Development 125(14): 2677-2685

Saxena, A.; Maxwell, D.M.; Quinn, D.M.; Radić, Z.; Taylor, P.; Doctor, B.P. 1997: Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning. Biochemical Pharmacology 54(2): 269-274

Weiss, R.S.; Gold, M.O.; Vogel, H.; Javier, R.T. 1997: Mutant adenovirus type 9 E4 ORF1 genes define three protein regions required for transformation of CREF cells. Journal of Virology 71(6): 4385-4394

Kupchella, E.; Koch, W.H.; Cebula, T.A. 1994: Mutant alleles of tRNA(Thr) genes suppress the hisG46 missense mutation in Salmonella typhimurium. Environmental and Molecular Mutagenesis 23(2): 81-88

Schmidt, U.; Maue, I.; Lehmann, K.; Belcher, S.M.; Stahl, U.; Perlman, P.S. 1998: Mutant alleles of the MRS2 gene of yeast nuclear DNA suppress mutations in the catalytic core of a mitochondrial group Ii intron. Journal of Molecular Biology 282(3): 525-541

Wong, Y.H.; Chan, J.S.; Yung, L.Y.; Bourne, H.R. 1995: Mutant alpha subunit of Gz transforms Swiss 3T3 cells. Oncogene 10(10): 1927-1933

Voyno-Yasenetskaya, T.A.; Pace, A.M.; Bourne, H.R. 1994: Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9(9): 2559-2565

Denis-Henriot, D.; de Mazancourt, P.; Morot, M.; Giudicelli, Y. 1998: Mutant alpha-subunit of the G protein G12 activates proliferation and inhibits differentiation of 3T3-F442A preadipocytes. Endocrinology 139(6): 2892-2899

Roberts, D.B.; Mulvany, W.J.; Dwek, R.A.; Rudd, P.M. 1998: Mutant analysis reveals an alternative pathway for N-linked glycosylation in Drosophila melanogaster. European Journal of Biochemistry 253(2): 494-498

Maksimenko, A.V. 1994: Mutant and hybrid protein derivatives for experimental therapy using plasminogen activators (a review). Khimiko Farmatsevticheskii Zhurnal 28(5): 4-11

Lehmann, S.; Harris, D.A. 1996: Mutant and infectious prion proteins display common biochemical properties in cultured cells. Journal of Biological Chemistry 271(3): 1633-1637

Howland, D.S.; Savage, M.J.; Huntress, F.A.; Wallace, R.E.; Schwartz, D.A.; Loh, T.; Melloni, R.H.; DeGennaro, L.J.; Greenberg, B.D.; Siman, R. 1995: Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain. Neurobiology of Aging 16(4): 685-699

Løvik, M. 1997: Mutant and transgenic mice in immunotoxicology: An introduction. Toxicology 119(1): 65-76

Yen, P.M.; Liu, Y.; Palvimo, J.J.; Trifiro, M.; Whang, J.; Pinsky, L.; Jänne, O.A.; Chin, W.W. 1997: Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. Molecular Endocrinology 11(2): 162-171

Culig, Z.; Hobisch, A.; Cronauer, M.V.; Cato, A.C.; Hittmair, A.; Radmayr, C.; Eberle, J.; Bartsch, G.; Klocker, H. 1993: Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molecular Endocrinology 7(12): 1541-1550

Ziak, M.; Jäger, J.; Malashkevich, V.N.; Gehring, H.; Jaussi, R.; Jansonius, J.N.; Christen, P. 1993: Mutant aspartate aminotransferase (K258H) without pyridoxal-5'-phosphate-binding lysine residue. Structural and catalytic properties. European Journal of Biochemistry 211(3): 475-484

Suckow, M.; Lopata, M.; Seydel, A.; Kisters-Woike, B.; von Wilcken-Bergmann, B.; Müller-Hill, B. 1996: Mutant bZip-DNA complexes with four quasi-identical protein-DNA interfaces. EMBO Journal 15(3): 598-606

Cetinkaya, G.; Cakmakci, M.L.tfu 1994: Mutant bacillus thuringiensis strains obtained by using ethyl-methane sulphonate. Mikrobiyoloji Bulteni 28(3): 271-278

Lyakhov, D.L.; He, B.; Zhang, X.; Studier, F.W.; Dunn, J.J.; McAllister, W.T. 1997: Mutant bacteriophage T7 RNA polymerases with altered termination properties. Journal of Molecular Biology 269(1): 28-40

De Vivo, I.; Marion, M.J.; Smith, S.J.; Carney, W.P.; Brandt-Rauf, P.W. 1994: Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride. Cancer Causes and Control: Ccc 5(3): 273-278

Leckett, B.; Spurmanis, A.; Allen, C.; Germinario, R.J. 1993: Mutant cell line demonstrating a block in insulin and insulin-like growth factor type 1 (IGF-1) induced mitogenesis. Journal of Cellular Physiology 155(1): 179-184

Menaker, M.; Vogelbaum, M.A. 1993: Mutant circadian period as a marker of suprachiasmatic nucleus function. Journal of Biological Rhythms 8(Suppl): S93-S98

Blagosklonny, M.V.; Toretsky, J.; Bohen, S.; Neckers, L. 1996: Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proceedings of the National Academy of Sciences of the United States of America 93(16): 8379-8383

Barber, D.L.; Ganz, M.B.; Bongiorno, P.B.; Strader, C.D. 1992: Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange. Molecular Pharmacology 41(6): 1056-1060

Gottlieb, R.A.; Dosanjh, A. 1996: Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: Possible relevance to cystic fibrosis. Proceedings of the National Academy of Sciences of the United States of America 93(8): 3587-3591

Bayliss, C.; Lasby, B.; Wood, J.M.; Lifshitz, R.; Brown, G.L. 1993: Mutant derivatives of Pseudomonas putida GR12-2R3 defective in nutrient utilization or cell surface structures show reduced ability to promote canola root elongation. Canadian Journal of Microbiology 39(12): 1111-1119

Pece, N.; Vera, S.; Cymerman, U.; White, R.I.; Wrana, J.L.; Letarte, M. 1997: Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. Journal of Clinical Investigation 100(10): 2568-2579

Mitsuzawa, H.; Esson, K.; Tamanoi, F. 1995: Mutant farnesyltransferase beta subunit of Saccharomyces cerevisiae that can substitute for geranylgeranyltransferase type I beta subunit. Proceedings of the National Academy of Sciences of the United States of America 92(5): 1704-1708

Wassarman, P.M.; Qi, H.; Litscher, E.S. 1997: Mutant female mice carrying a single mZP3 allele produce eggs with a thin zona pellucida, but reproduce normally. Proceedings. Biological Sciences 264(1380): 323-328

Liu, W.; Qian, C.; Comeau, K.; Brenn, T.; Furthmayr, H.; Francke, U. 1996: Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. Human Molecular Genetics 5(10): 1581-1587

Gishizky, M.L.; Cortez, D.; Pendergast, A.M. 1995: Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation. Proceedings of the National Academy of Sciences of the United States of America 92(24): 10889-10893

North, A.K.; Kustu, S. 1997: Mutant forms of the enhancer-binding protein NtrC can activate transcription from solution. Journal of Molecular Biology 267(1): 17-36

Lammers, R.; Møller, N.P.; Ullrich, A. 1998: Mutant forms of the protein tyrosine phosphatase alpha show differential activities towards intracellular substrates. Biochemical and Biophysical Research Communications 242(1): 32-38

Takahashi, S.; Kubota, Y.; Sato, H. 1998: Mutant frequencies in lacZ transgenic mice following the internal irradiation from 89Sr or the external gamma-ray irradiation. Journal of Radiation Research 39(1): 53-60

Klarmann, B.; Wixler, V.; Lorenz, R.; Hempel, K. 1995: Mutant frequency at the H-2K class 1 and HPRT genes in T lymphocytes from the X-ray-exposed mouse. International Journal of Radiation Biology 67(4): 421-430

Hirai, Y.; Kusunoki, Y.; Kyoizumi, S.; Awa, A.A.; Pawel, D.J.; Nakamura, N.; Akiyama, M. 1995: Mutant frequency at the HPRT locus in peripheral blood T-lymphocytes of atomic bomb survivors. Mutation Research 329(2): 183-196

Cheng, T.J.; Christiani, D.C.; Liber, H.L.; Wain, J.C.; Xu, X.; Wiencke, J.K.; Kelsey, K.T. 1995: Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer. Mutation Research 332(1-2): 109-118

Hori, K.; Saito, F.; Tokita, K.; Kurotsu, T.; Kanda, M.; Saito, Y. 1994: Mutant genes of gramicidin S synthetase 1 defective in phenylalanine racemization have the same sequence as the wild gene. Journal of Biochemistry 116(6): 1202-1204

Mao, C.; Davies, D.; Kerr, I.M.; Stark, G.R. 1993: Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma. Proceedings of the National Academy of Sciences of the United States of America 90(7): 2880-2884

Qian, S.; Jiang, P.; Guan, X.M.; Singh, G.; Trumbauer, M.E.; Yu, H.; Chen, H.Y.; Van de Ploeg, L.H.; Zheng, H. 1998: Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron 20(3): 611-617

Gao, Y.; Quan, H.; Jiang, M.; Dai, Y.; Wang, C.C. 1997: Mutant human protein disulfide isomerase assists protein folding in a chaperone-like fashion. Journal of Biotechnology 54(2): 105-112

Faure, E.; Gouédard, L.; Imbeaud, S.; Cate, R.; Picard, J.Y.; Josso, N.; di Clemente, N. 1996: Mutant isoforms of the anti-Müllerian hormone type II receptor are not expressed at the cell membrane. Journal of Biological Chemistry 271(48): 30571-30575

Kitamoto, K.; Oda Miyazaki, K.; Gomi, K.; Kumagai, C. 1993: Mutant isolation of non-urea producing sake yeast by positive selection. Journal of Fermentation and Bioengineering 75(5): 359-363

Yamada, M.; Inbe, H.; Tanaka, M.; Sumi, K.; Matsushita, K.; Adachi, O. 1998: Mutant isolation of the Escherichia coli quinoprotein glucose dehydrogenase and analysis of crucial residues Asp-730 and His-775 for its function. Journal of Biological Chemistry 273(34): 22021-22027

Harris, R.A.; McQuilkin, S.J.; Paylor, R.; Abeliovich, A.; Tonegawa, S.; Wehner, J.M. 1995: Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proceedings of the National Academy of Sciences of the United States of America 92(9): 3658-3662

Reddy, S.; Jin, P.; Trimarchi, J.; Caruccio, P.; Phillis, R.; Murphey, R.K. 1997: Mutant molecular motors disrupt neural circuits in Drosophila. Journal of Neurobiology 33(6): 711-723

Rosenfeld, J.V.; Richards, L.J.; Bartlett, P.F. 1993: Mutant mouse cerebellum does not provide specific signals for the selective migration and development of transplanted Purkinje cells. Neuroscience Letters 155(1): 19-23

Inoue, K.; Takai, D.; Soejima, A.; Isobe, K.; Yamasoba, T.; Oka, Y.; Goto, Y.; Hayashi, J. 1996: Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrial translation to streptomycin can be co-transferred to rho 0 HeLa cells. Biochemical and Biophysical Research Communications 223(3): 496-501

Dergousova, N.I.; Leonova, Y.F.; Zinchenko, A.A.; Rumsh, L.D.; Andreeva, N.S. 1997: Mutant of HIV-1 protease with new specific properties. Protein and Peptide Letters 4(5): 321-328

Ishibashi, Y.; Nobuta, K.; Arai, T. 1992: Mutant of Salmonella typhimurium lacking the inhibitory function for phagosome-lysosome fusion in murine macrophages. Microbial Pathogenesis 13(4): 317-323

Yamamoto-Honda, R.; Honda, Z.; Ueki, K.; Tobe, K.; Kaburagi, Y.; Takahashi, Y.; Tamemoto, H.; Suzuki, T.; Itoh, K.; Akanuma, Y.; Yazaki, Y.; Kadowaki, T. 1996: Mutant of insulin receptor substrate-1 incapable of activating phosphatidylinositol 3-kinase did not mediate insulin-stimulated maturation of Xenopus laevis oocytes. Journal of Biological Chemistry 271(45): 28677-28681

Bujo, H.; Yamamoto, T.; Hayashi, K.; Hermann, M.; Nimpf, J.; Schneider, W.J. 1995: Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility. Proceedings of the National Academy of Sciences of the United States of America 92(21): 9905-9909

Hachiya, M.; Chumakov, A.; Miller, C.W.; Akashi, M.; Said, J.; Koeffler, H.P. 1994: Mutant p53 proteins behave in a dominant, negative fashion in vivo. Anticancer Research 14(5a): 1853-1859

Henkler, F.; Waseem, N.; Golding, M.H.; Alison, M.R.; Koshy, R. 1995: Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Research 55(24): 6084-6091

Grant, S.W.; Kyshtoobayeva, A.S.; Kurosaki, T.; Jakowatz, J.; Fruehauf, J.P. 1998: Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detection and Prevention 22(3): 185-194

Rosanelli, G.P.; Steindorfer, P.; Wirnsberger, G.H.; Klimpfinger, M.; Ratschek, M.; Puerstner, P.; Auner, H.; Berhold, A. 1995: Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Anticancer Research 15(2): 581-586

Lai, R.; el Dabbagh, L.; Mourad, W.A. 1996: Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(6): 690-695

Van Veldhuizen, P.J.; Sadasivan, R.; Garcia, F.; Austenfeld, M.S.; Stephens, R.L. 1993: Mutant p53 expression in prostate carcinoma. Prostate 22(1): 23-30

Kainz, C.; Kohlberger, P.; Gitsch, G.; Sliutz, G.; Breitenecker, G.; Reinthaller, A. 1995: Mutant p53 in patients with invasive cervical cancer stages IB to IIB. Gynecologic Oncology 57(2): 212-214

Bristow, R.G.; Jang, A.; Peacock, J.; Chung, S.; Benchimol, S.; Hill, R.P. 1994: Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9(6): 1527-1536

Williams, A.C.; Miller, J.C.; Collard, T.J.; Bracey, T.S.; Cosulich, S.; Paraskeva, C. 1995: Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation. Oncogene 11(1): 141-149

U, H.S.; Banaie, A.; Rigby, L.; Chen, J. 1998: Mutant p53 may selectively suppress glial specific proteins in pluripotential human neuroectodermal tumor cells. Neuroscience Letters 244(1): 41-46

Stephenson, T.J.; Royds, J.; Silcocks, P.B.; Bleehen, S.S. 1992: Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. British Journal of Dermatology 127(6): 566-570

Kieser, A.; Weich, H.A.; Brandner, G.; Marmé, D.; Kolch, W. 1994: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9(3): 963-969

Gitsch, G.; Kainz, C.; Joura, E.; Breitenecker, G. 1992: Mutant p53 product in patients with stage IIi cervical cancer. Anticancer Research 12(6b): 2241-2242

Strang, P.; Nordstöm, B.; Nilsson, S.; Bergström, R.; Tribukait, B. 1996: Mutant p53 protein as a predictor of survival in endometrial carcinoma. European Journal of Cancer 32a(4): 598-602

Levesque, M.A.; Katsaros, D.; Yu, H.; Zola, P.; Sismondi, P.; Giardina, G.; Diamandis, E.P. 1995: Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 75(6): 1327-1338

Miller, C.W.; Chumakov, A.; Said, J.; Chen, D.L.; Aslo, A.; Koeffler, H.P. 1993: Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. Oncogene 8(7): 1815-1824

Bond, J.A.; Blaydes, J.P.; Rowson, J.; Haughton, M.F.; Smith, J.R.; Wynford-Thomas, D.; Wyllie, F.S. 1995: Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Research 55(11): 2404-2409

Gao, Q.; Hauser, S.H.; Liu, X.L.; Wazer, D.E.; Madoc-Jones, H.; Band, V. 1996: Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Research 56(13): 3129-3133

Oyama, F.; Sawamura, N.; Kobayashi, K.; Morishima-Kawashima, M.; Kuramochi, T.; Ito, M.; Tomita, T.; Maruyama, K.; Saido, T.C.; Iwatsubo, T.; Capell, A.; Walter, J.; Grünberg, J.; Ueyama, Y.; Haass, C.; Ihara, Y. 1998: Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. Journal of Neurochemistry 71(1): 313-322

Citron, M.; Westaway, D.; Xia, W.; Carlson, G.; Diehl, T.; Levesque, G.; Johnson-Wood, K.; Lee, M.; Seubert, P.; Davis, A.; Kholodenko, D.; Motter, R.; Sherrington, R.; Perry, B.; Yao, H.; Strome, R.; Lieberburg, I.; Rommens, J.; Kim, S.; Schenk, D.; Fraser, P.; St George Hyslop, P.; Selkoe, D.J. 1997: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine 3(1): 67-72

McGuinness, S.M.; Shibuya, M.L.; Ueno, A.M.; Vannais, D.B.; Waldren, C.A.; Chatterjee, A. 1995: Mutant quantity and quality in mammalian cells (AL) exposed to cesium-137 gamma radiation: effect of caffeine. Radiation Research 142(3): 247-255

Rak, J.; Mitsuhashi, Y.; Bayko, L.; Filmus, J.; Shirasawa, S.; Sasazuki, T.; Kerbel, R.S. 1995: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Research 55(20): 4575-4580

Maher, J.; Baker, D.; Dibb, N.; Roberts, I. 1996: Mutant ras promotes haemopoietic cell proliferation on a cell-specific manner. Leukemia (Basingstoke) 10(1): 83-90

Alb, J.G.; Gedvilaite, A.; Cartee, R.T.; Skinner, H.B.; Bankaitis, V.A. 1995: Mutant rat phosphatidylinositol/phosphatidylcholine transfer proteins specifically defective in phosphatidylinositol transfer: implications for the regulation of phospholipid transfer activity. Proceedings of the National Academy of Sciences of the United States of America 92(19): 8826-8830

Volkov, I.K.; Lysenko, A.S.; Chebotarev, A.N. 1993: Mutant spreading in heterogeneous surrounding with migration registration: Dynamics population closed model taking in account the number of different genotype individuals. Genetika 29(7): 1218-1225

Volkov, I.K.; Lysenko, A.S.; Chebotarev, A.N. 1993: Mutant spreading in nonhomogeneous environment of inhabitation with the account of migration: The general equation of the process. Genetika 29(3): 531-538

Lester, R.L.; Wells, G.B.; Oxford, G.; Dickson, R.C. 1993: Mutant strains of Saccharomyces cerevisiae lacking sphingolipids synthesize novel inositol glycerophospholipids that mimic sphingolipid structures. Journal of Biological Chemistry 268(2): 845-856

Matĕjů, J.; Marsálková, J.; Nohýnek, M.; Steinerová, N. 1991: Mutant strains of Streptomyces cinnamonensis protoplasts. Cultural and physiological conditions. Folia Microbiologica 36(1): 42-48

Müller, S.; Zimmermann, F.K.; Boles, E. 1997: Mutant studies of phosphofructo-2-kinases do not reveal an essential role of fructose-2,6-bisphosphate in the regulation of carbon fluxes in yeast cells. Microbiology 143: 3055-3061

Ghadge, G.D.; Lee, J.P.; Bindokas, V.P.; Jordan, J.; Ma, L.; Miller, R.J.; Roos, R.P. 1997: Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(22): 8756-8766

Evans, D.A.; Burbach, J.P.; Swaab, D.F.; van Leeuwen, F.W. 1996: Mutant vasopressin precursors in the human hypothalamus: Evidence for neuronal somatic mutations in man. Neuroscience 71(4): 1025-1030

Thornhill, R.; Dekker, J. 1993: Mutant weeds of Iowa: V. S-triazine resistant Setaria faberi Herrm. Journal of the Iowa Academy of Science 100(1): 13-14

Kew, M.C.; Miller, R.H.; Chen, H.S.; Tennant, B.C.; Purcell, R.H. 1993: Mutant woodchuck hepatitis virus genomes from virions resemble rearranged hepadnaviral integrants in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 90(21): 10211-10215

Sonsuz, A.; Ozdemir, S.; Ersanli, Z.; Basaran, E.G.; Senturk, H.; Akin, P.; Gurakar, M. 1993: Mutant-type chronic hepatitis B virus infections. Cerrahpasa Tip Fakultesi Dergisi 24(1): 37-42

Donlin, M.J.; Johnson, K.A. 1994: Mutants Affecting Nucleotide recognition by T7 DNA Polymerase. Biochemistry 33(49): 14908-14917

Jacoby, J.J.; Schmitz, H.P.; Heinisch, J.J. 1997: Mutants affected in the putative diacylglycerol binding site of yeast protein kinase C. Febs Letters 417(2): 219-222

Pickham, K.M.; Donoghue, D.J. 1994: Mutants at Ser277 of Xenopus cdc2 protein kinase induce oocyte maturation in the absence of the positive regulatory phosphorylation site Thr161. Molecular Biology of the Cell 5(5): 587-596

Russel, M. 1994: Mutants at conserved positions in gene IV, a gene required for assembly and secretion of filamentous phages. Molecular Microbiology 14(2): 357-369

Fierro, F.; Montenegro, E.; Gutiérrez, S.; Martín, J.F. 1996: Mutants blocked in penicillin biosynthesis show a deletion of the entire penicillin gene cluster at a specific site within a conserved hexanucleotide sequence. Applied Microbiology and Biotechnology 44(5): 597-604

Vuorio, R.; Vaara, M. 1992: Mutants carrying conditionally lethal mutations in outer membrane genes omsA and firA (ssc) are phenotypically similar, and omsA is allelic to firA. Journal of Bacteriology 174(22): 7090-7097

Archer, C.D.; Wang, X.; Elliott, T. 1993: Mutants defective in the energy-conserving NADH dehydrogenase of Salmonella typhimurium identified by a decrease in energy-dependent proteolysis after carbon starvation. Proceedings of the National Academy of Sciences of the United States of America 90(21): 9877-9881

Bachir, F.; Baise, E.; Loppes, R. 1996: Mutants impaired in derepressible alkaline phosphatase activity in Chlamydomonas reinhardtii. Plant Science 119(1-2): 93-101

Schlenstedt, G.; Wong, D.H.; Koepp, D.M.; Silver, P.A. 1995: Mutants in a yeast Ran binding protein are defective in nuclear transport. EMBO Journal 14(21): 5367-5378

Dailey, F.E.; Berg, H.C. 1993: Mutants in disulfide bond formation that disrupt flagellar assembly in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 90(3): 1043-1047

Rosenwald, A.G.; Stanley, P.; McLachlan, K.R.; Krag, S.S. 1993: Mutants in dolichol synthesis: conversion of polyprenol to dolichol appears to be a rate-limiting step in dolichol synthesis. Glycobiology 3(5): 481-488

Günes, C.; Müller-Hill, B. 1996: Mutants in position 69 of the Trp repressor of Escherichia coli K12 with altered DNA-binding specificity. Molecular and General Genetics: Mgg 251(3): 338-346

Yamamoto, S.; Takeda, Y.; Yamamoto, M.; Kurazono, H.; Imaoka, K.; Yamamoto, M.; Fujihashi, K.; Noda, M.; Kiyono, H.; McGhee, J.R. 1997: Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. Journal of Experimental Medicine 185(7): 1203-1210

Francis, M.S.; Thomas, C.J. 1997: Mutants in the CtpA copper transporting P-type ATPase reduce virulence of Listeria monocytogenes. Microbial Pathogenesis 22(2): 67-78

Fijalkowska, I.J.; Schaaper, R.M. 1996: Mutants in the Exo I motif of Escherichia coli dnaQ: Defective proofreading and inviability due to error catastrophe. Proceedings of the National Academy of Sciences of the United States of America 93(7): 2856-2861

Pichová, A.; Vondráková, D.; Breitenbach, M. 1997: Mutants in the Saccharomyces cerevisiae RAS2 gene influence life span, cytoskeleton, and regulation of mitosis. Canadian Journal of Microbiology 43(8): 774-781

Adamo, H.P.; Filoteo, A.G.; Enyedi, A.; Penniston, J.T. 1995: Mutants in the putative nucleotide-binding region of the plasma membrane Ca(2+)-pump. A reduction in activity due to slow dephosphorylation. Journal of Biological Chemistry 270(50): 30111-30114

Shelden, E.; Knecht, D.A. 1995: Mutants lacking myosin Ii cannot resist forces generated during multicellular morphogenesis. Journal of Cell Science 108: 1105-1115

McLean, B.G.; Greene, E.A.; Zambryski, P.C. 1994: Mutants of Agrobacterium VirA that activate vir gene expression in the absence of the inducer acetosyringone. Journal of Biological Chemistry 269(4): 2645-2651

Frolova, V.D.; Muronets, E.M.; Mitronova, T.N.; Belavina, N.V.; Kameneva, S.V.; Shestakov, S.V. 1994: Mutants of Agrobacterium radiobacter altered in nitrogen metabolism and associative interaction with plants. Mikrobiologiya 63(2): 239-246

Bharti, A.K.; Khurana, J.P. 1997: Mutants of Arabidopsis as tools to understand the regulation of phenylpropanoid pathway and UVB protection mechanisms. Photochemistry and Photobiology 65(5): 765-776

Browse, J.; McConn, M.; James, D.; Miquel, M. 1993: Mutants of Arabidopsis deficient in the synthesis of alpha-linolenate. Biochemical and genetic characterization of the endoplasmic reticulum linoleoyl desaturase. Journal of Biological Chemistry 268(22): 16345-16351

Soldatova, O.P.; Ezhova, T.A.; Ondar, U.N.; Gostimskii, S.A.; Konrad, U.; Artsaenko, O. 1996: Mutants of Arabidopsis thaliana (L.) Heynh. tolerant to norflurazon, an inhibitor of carotenoid biosynthesis. Genetika 32(7): 956-961

Mita, S.; Murano, N.; Akaike, M.; Nakamura, K. 1997: Mutants of Arabidopsis thaliana with pleiotropic effects on the expression of the gene for beta-amylase and on the accumulation of anthocyanin that are inducible by sugars. Plant Journal: for Cell and Molecular Biology 11(4): 841-851

Clutterbuck, A.J. 1994: Mutants of Aspergillus nidulans deficient in nuclear migration during hyphal growth and conidiation. Microbiology 140: 1169-1174

E.M., A.; Dubertret, G.; Delrieu, M.J.; Roche, O.; Tremolieres, A. 1998: Mutants of Chlamydomonas reinhardtii affected in phosphatidylglycerol metabolism and thylakoid biogenesis. Plant Physiology and Biochemistry (Paris) 36(8): 609-619,

Davies, J.. P..; Yildiz, F..; Grossman, A.. R.. 1994: Mutants of Chlamydomonas with Aberrant Responses to Sulfur Deprivation. Plant Cell 6(1): 53-63

Okazaki, N.; Xu, X.J.; Shimamoto, T.; Kuroda, M.; Wilson, T.H.; Tsuchiya, T. 1998: Mutants of Citrobacter freundii that transport and utilize melibiose. Journal of Bacteriology 180(13): 3480-3482

Asano, Y.; Yamaguchi, K. 1995: Mutants of D-aminopeptidase with increased thermal stability. Journal of Fermentation and Bioengineering 79(6): 614-616

Wetterauer, B.; Jacobsen, G.; Morandini, P.; MacWilliams, H. 1993: Mutants of Dictyostelium discoideum with defects in the regulation of discoidin i expression. Developmental Biology 159(1): 184-195

Abdulkarim, F.; Ehrenberg, M.; Hughes, D. 1996: Mutants of EF-Tu defective in binding aminoacyl-tRNA. Febs Letters 382(3): 297-303

Kim, O.J.; Yates, J.L. 1993: Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. Journal of Virology 67(12): 7634-7640

Mangroo, D.; RajBhandary, U.L. 1995: Mutants of Escherichia coli initiator tRNA defective in initiation. Effects of overproduction of methionyl-tRNA transformylase and the initiation factors IF2 and IF3. Journal of Biological Chemistry 270(20): 12203-12209

Reed, K.E.; Morris, T.W.; Cronan, J.E. 1994: Mutants of Escherichia coli K-12 that are resistant to a selenium analog of lipoic acid identify unknown genes in lipoate metabolism. Proceedings of the National Academy of Sciences of the United States of America 91(9): 3720-3724

Pfau, J.; Arvidson, D.N.; Youderian, P. 1994: Mutants of Escherichia coli Trp repressor with changes of conserved, helix-turn-helix residue threonine 81 have altered DNA-binding specificities. Molecular Microbiology 13(6): 1001-1012

Komase, K.; Tamura, S.; Matsuo, K.; Watanabe, K.; Hattori, N.; Odaka, A.; Suzuki, Y.; Kurata, T.; Aizawa, C. 1998: Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine. Vaccine 16(2-3): 248-254

Douce, G.; Turcotte, C.; Cropley, I.; Roberts, M.; Pizza, M.; Domenghini, M.; Rappuoli, R.; Dougan, G. 1995: Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proceedings of the National Academy of Sciences of the United States of America 92(5): 1644-1648

Hales, L.M.; Gumport, R.I.; Gardner, J.F. 1994: Mutants of Escherichia coli integration host factor: DNA-binding and recombination properties. Biochimie 76(10-11): 1030-1040

Sambongi, Y.; Ferguson, S.J. 1996: Mutants of Escherichia coli lacking disulphide oxidoreductases DsbA and DsbB cannot synthesise an exogenous monohaem c-type cytochrome except in the presence of disulphide compounds. Febs Letters 398(2-3): 265-268

Fijalkowska, I.J.; Dunn, R.L.; Schaaper, R.M. 1993: Mutants of Escherichia coli with increased fidelity of DNA replication. Genetics 134(4): 1023-1030

Page, M.D.; Ferguson, S.J. 1993: Mutants of Methylobacterium extorquens and Paracoccus denitrificans deficient in c-type cytochrome biogenesis synthesise the methylamine-dehydrogenase polypeptides but cannot assemble the tryptophan-tryptophylquinone group. European Journal of Biochemistry 218(2): 711-717

Chang, B.Y.; Dworkin, M. 1996: Mutants of Myxococcus xanthus dsp defective in fibril binding. Journal of Bacteriology 178(3): 697-700

Linden, H.; Rodriguez-Franco, M.; Macino, G. 1997: Mutants of Neurospora crassa defective in regulation of blue light perception. Molecular and general genetics: MGG 254(2): 111-118

Madi, L.; Ebbole, D.J.; White, B.T.; Yanofsky, C. 1994: Mutants of Neurospora crassa that alter gene expression and conidia development. Proceedings of the National Academy of Sciences of the United States of America 91(13): 6226-6230

Colocousi, A.S.qib, K.; Leak, D. 1996: Mutants of Pseudomonas fluorescens NCIMB 11671 defective in the catabolism of alpha-pinene. Applied microbiology and biotechnology 45(6): 822-830

Ren, Q.; Kessler, B.; Van Der Leij, F.; Witholt, B. 1998: Mutants of Pseudomonas putida affected in poly-3-hydroxyalkanoate synthesis. Applied Microbiology and Biotechnology 49(6): 743-750

Brondyk, W.H.; McKiernan, C.J.; Burstein, E.S.; Macara, I.G. 1993: Mutants of Rab3A analogous to oncogenic Ras mutants. Sensitivity to Rab3A-GTPase activating protein and Rab3A-guanine nucleotide releasing factor. Journal of Biological Chemistry 268(13): 9410-9415

Ramsay, L.M.; Gadd, G.M. 1997: Mutants of Saccharomyces cerevisiae defective in vacuolar function confirm a role for the vacuole in toxic metal ion detoxification. Fems Microbiology Letters 152(2): 293-298

Krems, B.; Charizanis, C.; Entian, K.D. 1995: Mutants of Saccharomyces cerevisiae sensitive to oxidative and osmotic stress. Current Genetics 27(5): 427-434

McCammon, M.T. 1996: Mutants of Saccharomyces cerevisiae with defects in acetate metabolism: isolation and characterization of Acn- mutants. Genetics 144(1): 57-69

Buchan, T.; Roach, C.; Ruby, C.; Taylor, D.; Preisig, C.; Reeves, C. 1994: Mutants of Streptomyces cattleya defective in the synthesis of a factor required for thienamycin production. Journal of Antibiotics 47(9): 992-1000

Hosted, T.J.; Baltz, R.H. 1996: Mutants of Streptomyces roseosporus that express enhanced recombination within partially homologous genes. Microbiology 142: 2803-2813

Kostyuk, D.A.; Dragan, S.M.; Lyakhov, D.L.; Rechinsky, V.O.; Tunitskaya, V.L.; Chernov, B.K.; Kochetkov, S.N. 1995: Mutants of T7 RNA polymerase that are able to synthesize both RNA and DNA. Febs Letters 369(2-3): 165-168

Torigoi, E.; Henrique-Silva, F.; Escobar-Vera, J.; Carle-Urioste, J.C.; Crivellaro, O.; El-Dorry, H.; El-Gogary, S. 1996: Mutants of Trichoderma reesei are defective in cellulose induction, but not basal expression of cellulase-encoding genes. Gene 173(2): 199-203

Just, U.; Spooncer, E.; Löhler, J.; Stocking, C.; Ostertag, W.; Dexter, T.M. 1994: Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo. Experimental Hematology 22(9): 933-940

Mehta, B.; Cerda-Olmedo, E. 1995: Mutants of carotene production in Blakeslea trispora. Applied microbiology and biotechnology 42(6): 836-838

Iannelli, D.; Palomba, R.; Capparelli, R.; Scala, F.; Iannelli, A.; Ferrara, L.; Uchida, T. 1994: Mutants of cultured mouse cells deficient in Ly-2 antigen. Immunogenetics 40(2): 154-158

Lenhart, K.; Merkunová, A. 1994: Mutants of dermatophytes resistant to ketoconazole. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 137: 15-17

Vasilescu, S.; Ptushkina, M.; Linz, B.; Müller, P.P.; McCarthy, J.E. 1996: Mutants of eukaryotic initiation factor eIF-4E with altered mRNA cap binding specificity reprogram mRNA selection by ribosomes in Saccharomyces cerevisiae. Journal of Biological Chemistry 271(12): 7030-7037

Trymbulak, W.P.; Zeff, R.A. 1997: Mutants of human beta2-microglobulin map an immunodominant epitope within the three-stranded beta-pleated sheet. Transplantation 64(4): 640-645

Purohit, S.; Shao, K.; Balasubramanian, S.V.; Bahl, O.P. 1997: Mutants of human choriogonadotropin lacking N-glycosyl chains in the alpha-subunit. 1. Mechanism for the differential action of the N-linked carbohydrates. Biochemistry 36(40): 12355-12363

Grigor'eva, T.M.; Smirnova, T.A.; Azizbekyan, R.R. 1993: Mutants of phages of Gluconobacter oxydans with altered host specificity. Biotekhnologiya 1993(9): 6-10

Richieri, G.V.; Low, P.J.; Ogata, R.T.; Kleinfeld, A.M. 1997: Mutants of rat intestinal fatty acid-binding protein illustrate the critical role played by enthalpy-entropy compensation in ligand binding. Journal of Biological Chemistry 272(27): 16737-16740

Li, J.; Cook, R.; Chaiken, I. 1996: Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits. Journal of Biological Chemistry 271(49): 31729-31734

Matsushima, S.; Huang, Y.P.; Dudas, C.V.; Guerriero, V.; Hartshorne, D.J. 1994: Mutants of smooth muscle myosin light chain kinase at tryptophan 800. Biochemical and Biophysical Research Communications 202(3): 1329-1336

Ahmed, M.; Borsch, C.M.; Neyfakh, A.A.; Schuldiner, S. 1993: Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. Journal of Biological Chemistry 268(15): 11086-11089

Eckhardt, M.; Gotza, B.; Gerardy-Schahn, R. 1998: Mutants of the CMP-sialic acid transporter causing the Lec2 phenotype. Journal of Biological Chemistry 273(32): 20189-20195

Endow, S.A.; Chandra, R.; Komma, D.J.; Yamamoto, A.H.; Salmon, E.D. 1994: Mutants of the Drosophila ncd microtubule motor protein cause centrosomal and spindle pole defects in mitosis. Journal of Cell Science 107: 859-867

de Haan, L.; Verweij, W.R.; Feil, I.K.; Lijnema, T.H.; Hol, W.G.; Agsteribbe, E.; Wilschut, J. 1996: Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infection and Immunity 64(12): 5413-5416

Barber, G.N.; Wambach, M.; Thompson, S.; Jagus, R.; Katze, M.G. 1995: Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Molecular and Cellular Biology 15(6): 3138-3146

Lecuyer, K.A.; Behlen, L.S.; Uhlenbeck, O.C. 1995: Mutants of the bacteriophage MS2 coat protein that alter its cooperative binding to RNA. Biochemistry 34(33): 10600-10606

Navarro, E.; Sandmann, G.; Torres Martinez, S. 1995: Mutants of the carotenoid biosynthetic pathway of Mucor circinelloides. Experimental Mycology. : 186-190

Mikheeva, L.E.; Schmitz, O.; Shestakov, S.V.; Bothe, H. 1995: Mutants of the cyanobacterium Anabaena variabilis altered in hydrogenase activities. Zeitschrift fuer Naturforschung Section C Biosciences 50(7-8): 505-510

Stasyk, O.V.; Ksheminskaya, G.P.; Kulachkovskii, A.R.; Sibirnyi, A.A. 1997: Mutants of the methylotrophic yeast Hansenula polymorpha with impaired catabolite repression. Mikrobiologiya 66(6): 755-760

Ward, C.D.; Paterson, R.G.; Lamb, R.A. 1995: Mutants of the paramyxovirus SV5 fusion protein: regulated and extensive syncytium formation. Virology 209(1): 242-249

Yukioka, H.; Tanaka, R.; Inagaki, S.; Katoh, K.; Miki, N.; Mizutani, A.; Masuko, M.; Kunoh, H. 1997: Mutants of the phytopathogenic fungus Magnaporthe grisea deficient in alternative, cyanide-resitant, respiration. Fungal Genetics and Biology 22(3): 221-228

Weinstein, M.; Lois, A.F.; Ditta, G.S.; Helinski, D.R. 1993: Mutants of the two-component regulatory protein FixJ of Rhizobium meliloti that have increased activity at the nifA promoter. Gene 134(2): 145-152

Titorenko, V.I.; Rachubinski, R.A. 1998: Mutants of the yeast Yarrowia lipolytica defective in protein exit from the endoplasmic reticulum are also defective in peroxisome biogenesis. Molecular and Cellular Biology 18(5): 2789-2803

Chalupová, V. 1998: Mutants of Trichophyton mentagrophytes with changed optimum cultivation temperature. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 141: 17-19

Prosvirova, T.Y.; Polodienko, O.B.; Tolstorukov, I.I. 1993: Mutants of yeast Candida utilis with high level of lysine in amino acid pool. Biotekhnologiya 1993(10): 2-7

Fukuda, K.; Muromachi, A.; Watanabe, M.; Asano, K.; Takasawa, S. 1993: Mutants producing high concentrations of the flavor components active amyl alcohol and normal propanol in Saccharomyces cerevisiae. Journal of Fermentation and Bioengineering 75(4): 288-292

Leslie, J.F.; Zeller, K. 1997: Mutants that blur the line between biological species and vegetative compatibility groups. Cereal Research Communications 25(3 Part 2): 539-542

Juhnke, H.; Krems, B.; Kötter, P.; Entian, K.D. 1996: Mutants that show increased sensitivity to hydrogen peroxide reveal an important role for the pentose phosphate pathway in protection of yeast against oxidative stress. Molecular and General Genetics: Mgg 252(4): 456-464

Suzuki, S.; Katagiri, S.; Nakashima, H. 1996: Mutants with altered sensitivity to a calmodulin antagonist affect the circadian clock in Neurospora crassa. Genetics 143(3): 1175-1180

Teng, Y.; Longhese, M.; McDonough, G.; Waters, R. 1998: Mutants with changes in different domains of yeast replication protein a exhibit differences in repairing the control region, the transcribed strand and the non-transcribed strand of the Saccharomyces cerevisiae MFA2 gene. Journal of Molecular Biology 280(3): 355-363

Blat, Y.; Eisenbach, M. 1996: Mutants with defective phosphatase activity show no phosphorylation-dependent oligomerization of CheZ. the phosphatase of bacterial chemotaxis. Journal of Biological Chemistry 271(2): 1232-1236

Simpson, D.R.; Withers, J.M.; Wiebe, M.G.; Robson, G.D.; Trinci, A.P.J. 1998: Mutants with general growth rate advantages are the predominant morphological mutants to be isolated from the Quorn production plant. Mycological Research 102(2): 221-227,.

Breul, A.; Assmann, H.; Golz, R.; von Wilcken-Bergmann, B.; Müller-Hill, B. 1993: Mutants with substitutions for Glu171 in the catabolite activator protein (CAP) of Escherichia coli activate transcription from the lac promoter. Molecular and General Genetics: Mgg 238(1-2): 155-160

Ciferri, Orio; Tiboni, Orsola; Riccardi, Giovanna; Sanangelantoni, Anna Maria; De Rossi, Edda; Milano, Anna; Di Pasquale, Giuseppe 1993: Mutants, genes, and phylogeny of Spirulina platensis. Bulletin de l'Institut Oceanographique (Monaco) 1993(SPEC ISSUE 12): 25-29

Melander, C.; Horne, D.A. 1997: Mutarotation of tetramethylglucose catalyzed by ribonucleosides. Tetrahedron Letters 38(5): 713-716

Blom, H.J. 1998: Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia. European Journal of Pediatrics 157(Suppl): S131-S134

Mielnicki, L.M.; Hughes, R.G.; Chevray, P.M.; Pruitt, S.C. 1996: Mutated Atf4 suppresses c-Ha-ras oncogene transcript levels and cellular transformation in NIH3T3 fibroblasts. Biochemical and Biophysical Research Communications 228(2): 586-595

Gu, Z.; Arts, E.J.; Parniak, M.A.; Wainberg, M.A. 1995: Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs. Proceedings of the National Academy of Sciences of the United States of America 92(7): 2760-2764

Yin, S.; Luo, M. 1998: Mutated and screened the mutants of the Candida boidinii No. 2201 with biomass accumulation were achieved. Sichuan Daxue Xuebao (Ziran Kexueban) 35(1): 119-123

Gopalakrishnan, R.; Weghorst, C.M.; Lehman, T.A.; Calvert, R.J.; Bijur, G.; Sabourin, C.L.; Mallery, S.R.; Schuller, D.E.; Stoner, G.D. 1997: Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 83(4): 471-477

Schaeffer, B.K.; Glasner, S.; Kuhlmann, E.; Myles, J.L.; Longnecker, D.S. 1994: Mutated c-K-ras in small pancreatic adenocarcinomas. Pancreas 9(2): 161-165

Omori, Y.; Yamasaki, H. 1998: Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. International Journal of Cancer 78(4): 446-453

Shiau, A.L.; Murray, K. 1997: Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen. Journal of Medical Virology 51(3): 159-166

Tugizov, S.; Wang, Y.; Qadri, I.; Navarro, D.; Maidji, E.; Pereira, L. 1995: Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology 209(2): 580-591

Monaco, C.; Califano, D.; Chiappetta, G.; Mineo, A.; De Franciscis, V.; Vecchio, G.; Santelli, G. 1995: Mutated human Kirsten ras, driven by a thyroglobulin promoter, induces a growth advantage and partially dedifferentiates rat thyroid epithelial cells in vitro. International Journal of Cancer 63(5): 757-760

Elo, J.P.; Kvist, L.; Leinonen, K.; Isomaa, V.; Henttu, P.; Lukkarinen, O.; Vihko, P. 1995: Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. Journal of Clinical Endocrinology and Metabolism 80(12): 3494-3500

Suzuki, S.; Taneda, Y.; Hirai, S.; Yamamoto-Honda, R.; Toyota, T. 1992: Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes 41(11): 1373-1379

van der Put, N.M.; Steegers-Theunissen, R.P.; Frosst, P.; Trijbels, F.J.; Eskes, T.K.; van den Heuvel, L.P.; Mariman, E.C.; den Heyer, M.; Rozen, R.; Blom, H.J. 1995: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346(8982): 1070-1071

Ikeda, H.; Ohta, N.; Furukawa, K.; Miyazaki, H.; Wang, L.; Kuribayashi, K.; Old, L.J.; Shiku, H. 1997: Mutated mitogen-activated protein kinase: A tumor rejection antigen of mouse sarcoma. Proceedings of the National Academy of Sciences of the United States of America 94(12): 6375-6379

Lund, A.H.; Duch, M.; Lovmand, J.; Jørgensen, P.; Pedersen, F.S. 1993: Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. Journal of Virology 67(12): 7125-7130

Gjertsen, M.K.; Gaudernack, G. 1998: Mutated ras peptides as vaccines in immunotherapy of cancer. Vox Sanguinis 74(Suppl): 489-495

Sewell, A.K.; Yokoya, F.; Yu, W.; Miyagawa, T.; Murayama, T.; Winge, D.R. 1995: Mutated yeast heat shock transcription factor exhibits elevated basal transcriptional activation and confers metal resistance. Journal of Biological Chemistry 270(42): 25079-25086

Charalambidis, N.D.; Lambropoulou, M.; Marmaras, V.J. 1994: Mutation "white pupae" in the integument of Ceratitis capitata affects both defense and melanogenesis. Developmental and Comparative Immunology 18(3): 193-200

Nozaki, O.; Suzuki, Y.; Shimada, F.; Hashimoto, N.; Taira, M.; Hatanaka, Y.; Notoya, Y.; Kanashiro, O.; Makino, H.; Yoshida, S. 1993: Mutation (Gly-1008 fwdarw Val) of the insulin-receptor gene in a woman with type A insulin resistance. Journal of the Japan Diabetes Society 36(12): 943-949

Norrgard, K.J.; Pomponio, R.J.; Swango, K.L.; Hymes, J.; Reynolds, T.R.; Buck, G.A.; Wolf, B. 1997: Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. Biochemical and Molecular Medicine 61(1): 22-27

Montfort, M.; Vilageliu, L.; Garcia-Giralt, N.; Guidi, S.; Coll, M.J.; Chabás, A.; Grinberg, D. 1998: Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type a patients. Human Mutation 12(4): 274-279

Igaki, H.; Sasaki, H.; Tachimori, Y.; Kato, H.; Watanabe, H.; Kimura, T.; Harada, Y.; Sugimura, T.; Terada, M. 1995: Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Research 55(15): 3421-3423

Terskikh, A., V.; Potekhin, S., A.; Melnik, T., N.; Kajava, A., V. 1997: Mutation Gln54Leu of the conserved polar residue in the interfacial coiled coil position (d) results in significant stabilization of the original structure of the COMP pentamerization domain. Letters in Peptide Science 4(4-6): 297-304

Masson, P.; Froment, M.T.; Sorenson, R.C.; Bartels, C.F.; Lockridge, O. 1994: Mutation His322Asn in human acetylcholinesterase does not alter electrophoretic and catalytic properties of the erythrocyte enzyme. Blood 83(10): 3003-3005

Dulhanty, A.M.; Chang, X.B.; Riordan, J.R. 1995: Mutation of potential phosphorylation sites in the recombinant R domain of the cystic fibrosis transmembrane conductance regulator has significant effects on domain conformation. Biochemical and Biophysical Research Communications 206(1): 207-214

Yamagata, K.; Yang, Q.; Yamamoto, K.; Iwahashi, H.; Miyagawa, J.; Okita, K.; Yoshiuchi, I.; Miyazaki, J.; Noguchi, T.; Nakajima, H.; Namba, M.; Hanafusa, T.; Matsuzawa, Y. 1998: Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes 47(8): 1231-1235

Jaffrézou, J.P.; Chen, K.G.; Durán, G.E.; Kühl, J.S.; Sikic, B.I. 1994: Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. Journal of the National Cancer Institute 86(15): 1152-1158

Nissen, H.; Hansen, P.S.; Faergeman, O.; Hørder, M. 1995: Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis. Clinical Chemistry 41(3): 419-423

Peter, M.; Bünger, K.; Sólyom, J.; Sippell, W.G. 1998: Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II. European Journal of Pediatrics 157(5): 378-381

Betts, S.D.; Ross, J.R.; Pichersky, E.; Yocum, C.F. 1997: Mutation Val235Ala weakens binding of the 33-kDa manganese stabilizing protein of photosystem Ii to one of two sites. Biochemistry 36(13): 4047-4053

Lynch, M. 1997: Mutation accumulation in nuclear, organelle, and prokaryotic transfer RNA genes. Molecular Biology and Evolution 14(9): 914-925

Lynch, M. 1996: Mutation accumulation in transfer RNAs: molecular evidence for Muller's ratchet in mitochondrial genomes. Molecular Biology and Evolution 13(1): 209-220

Bjørheim, J.; Lystad, S.; Lindblom, A.; Kressner, U.; Westring, S.; Wahlberg, S.; Lindmark, G.; Gaudernack, G.; Ekstrøm, P.; Røe, J.; Thilly, W.G.; Børresen-Dale, A.L. 1998: Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction. Mutation Research 403(1-2): 103-112

Kurath, G.; Dodds, J.A. 1995: Mutation analyses of molecularly cloned satellite tobacco mosaic virus during serial passage in plants: evidence for hotspots of genetic change. Rna 1(5): 491-500

Murata, Y.; Kodama, H.; Abe, T.; Ishida, N.; Nishimura, M.; Levinson, B.; Gitschier, J.; Packman, S. 1997: Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease. Pediatric Research 42(4): 436-442

Slavc, I.; Rodriguez, I.R.; Mazuruk, K.; Chader, G.J.; Biegel, J.A. 1997: Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors. International Journal of Cancer 72(2): 277-282

Wengler, G.S.; Giliani, S.; Fiorini, M.; Mella, P.; Mantuano, E.; Zanola, A.; Pollonini, G.; Eibl, M.M.; Ugazio, A.G.; Notarangelo, L.D.; Parolini, O. 1998: Mutation analysis by a non-radioactive single-strand conformation polymorphism assay in nine families with X-linked severe combined immunodeficiency (SCIDX1). British Journal of Haematology 101(3): 586-591

Traystman, M.D.; Schulte, N.A.; MacDonald, M.; Anderson, J.R.; Sanger, W.G. 1994: Mutation analysis for cystic fibrosis to determine carrier status in 167 sperm donors from the Nebraska Genetic Semen Bank. Human Mutation 4(4): 271-275

Chevalier-Porst, F.; Bozon, D.; Bonardot, A.M.; Bruni, N.; Mithieux, G.; Mathieu, M.; Maire, I. 1996: Mutation analysis in 24 French patients with glycogen storage disease type 1a. Journal of Medical Genetics 33(5): 358-360

Hatton, C.E.; Cooper, A.; Whitehouse, C.; Wraith, J.E. 1997: Mutation analysis in 46 British and Irish patients with Gaucher's disease. Archives of Disease in Childhood 77(1): 17-22

Chevalier-Porst, F.; Bonardot, A.M.; Gilly, R.; Chazalette, J.P.; Mathieu, M.; Bozon, D. 1994: Mutation analysis in 600 French cystic fibrosis patients. Journal of Medical Genetics 31(7): 541-544

Katz, F.; Hinshelwood, S.; Rutland, P.; Jones, A.; Kinnon, C.; Morgan, G. 1996: Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Human Mutation 8(3): 223-228

Todoroya, A.; Bronzova, J.; Miorin, M.; Rosa, M.; Kremensky, I.; Danieli, G.A. 1996: Mutation analysis in Duchenne and Becker muscular dystrophy patients from Bulgaria shows a peculiar distribution of breakpoints by intron. American Journal of Medical Genetics 65(1): 40-43

Ozgüç, M.; Ozalp, I.; Coşkun, T.; Yilmaz, E.; Erdem, H.; Ayter, S. 1993: Mutation analysis in Turkish phenylketonuria patients. Journal of Medical Genetics 30(2): 129-130

Callis, M.; Jansen, S.; Thiart, R.; de Villiers, J.N.; Raal, F.J.; Kotze, M.J. 1998: Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations. Molecular and Cellular Probes 12(3): 149-152

Guldberg, P.; Levy, H.L.; Koch, R.; Berlin, C.M.; Francois, B.; Henriksen, K.F.; Güttler, F. 1994: Mutation analysis in families with discordant phenotypes of phenylalanine hydroxylase deficiency. Inheritance and expression of the hyperphenylalaninaemias. Journal of Inherited Metabolic Disease 17(6): 645-651

Livshits, L.A.; Kravchenko, S.A.; Musienko, S.I.; Malyarchuk, S.H. 1995: Mutation analysis in gene of mucoviscidosis: The origin and distribution of delF508 major mutation in Ukraine. Tsitologiya i Genetika 29(6): 67-73

Beutler, E.; Gelbart, T.; West, C.; Lee, P.; Adams, M.; Blackstone, R.; Pockros, P.; Kosty, M.; Venditti, C.P.; Phatak, P.D.; Seese, N.K.; Chorney, K.A.; Ten Elshof, A.E.; Gerhard, G.S.; Chorney, M. 1996: Mutation analysis in hereditary hemochromatosis. Blood Cells Molecules and Diseases 22(2): 187-194; Discussion 194a-194b

Vorgerd, M.; Kubisch, C.; Burwinkel, B.; Reichmann, H.; Mortier, W.; Tettenborn, B.; Pongratz, D.; Lindemuth, R.; Tegenthoff, M.; Malin, J.P.; Kilimann, M.W. 1998: Mutation analysis in myophosphorylase deficiency (McArdle's disease). Annals of Neurology 43(3): 326-331

Davis, M.B.; Bateman, D.; Quinn, N.P.; Marsden, C.D.; Harding, A.E. 1994: Mutation analysis in patients with possible but apparently sporadic Huntington's disease. Lancet 344(8924): 714-717

Miki, Y.; Katagiri, T.; Kasumi, F.; Yoshimoto, T.; Nakamura, Y. 1996: Mutation analysis in the BRCA2 gene in primary breast cancer. Nature Genetics 13(2): 245-247

Deufel, T.; Rabe, H.; Wieser, T.; Meitinger, T.; Rosenecker, J.; Bertele-Harms, R.; Harms, K.; Hadorn, H.B.; Roscher, A.A. 1993: Mutation analysis in the diagnosis of cystic fibrosis. European Journal of Pediatrics 152(11): 909-911

Isogai, K.; Sukegawa, K.; Tomatsu, S.; Fukao, T.; Song, X.Q.; Yamada, Y.; Fukuda, S.; Orii, T.; Kondo, N. 1998: Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). Journal of Inherited Metabolic Disease 21(1): 60-70

Ciotta, C.; Dogliotti, E.; Bignami, M. 1995: Mutation analysis in two newly identified rat p53 pseudogenes. Mutagenesis 10(2): 123-128

Eydmann, M.E.; Knowles, M.A. 1997: Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer. Cancer Genetics and Cytogenetics 93(2): 167-171

Friedman, L.S.; Gayther, S.A.; Kurosaki, T.; Gordon, D.; Noble, B.; Casey, G.; Ponder, B.A.; Anton-Culver, H. 1997: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. American Journal of Human Genetics 60(2): 313-319

Beltinger, C.; Böhler, T.; Karawajew, L.; Ludwig, W.D.; Schrappe, M.; Debatin, K.M. 1998: Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia. British Journal of Haematology 102(3): 722-728

Puck, J.M.; Pepper, A.E.; Henthorn, P.S.; Candotti, F.; Isakov, J.; Whitwam, T.; Conley, M.E.; Fischer, R.E.; Rosenblatt, H.M.; Small, T.N.; Buckley, R.H. 1997: Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89(6): 1968-1977

Ben Simon-Schiff, E.; Bach, G.; Hopwood, J.J.; Abeliovich, D. 1994: Mutation analysis of Jewish Hunter patients in Israel. Human Mutation 4(4): 263-270

Lin, S.Y.; Chen, P.H.; Wang, C.K.; Liu, J.D.; Siauw, C.P.; Chen, Y.J.; Yang, M.J.; Liu, M.H.; Chen, T.C.; Chang, J.G. 1993: Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. American Journal of Clinical Pathology 100(6): 686-689

Kok, R.G.; D'Argenio, D.A.; Ornston, L.N. 1998: Mutation analysis of PobR and PcaU, closely related transcriptional activators in acinetobacter. Journal of Bacteriology 180(19): 5058-5069

Foulkes, W.D.; Englefield, P.; Campbell, I.G. 1994: Mutation analysis of RASK and the 'FLR Exon' of NF1 in sporadic ovarian carcinoma. European Journal of Cancer 30A(4): 528-530

Zhou, C.; Jong, A.Y. 1993: Mutation analysis of Saccharomyces cerevisiae CDC6 promoter: defining its UAS domain and cell cycle regulating element. Dna and Cell Biology 12(4): 363-370

Malzac, P.; Webber, H.; Moncla, A.; Graham, J.M.; Kukolich, M.; Williams, C.; Pagon, R.A.; Ramsdell, L.A.; Kishino, T.; Wagstaff, J. 1998: Mutation analysis of UBE3A in Angelman syndrome patients. American Journal of Human Genetics 62(6): 1353-1360

Goldblatt, J.; Creegan, R.; Edkins, T.; Landau, L.I.; Ryan, G.; Walpole, I.R. 1995: Mutation analysis of Western Australian families affected by cystic fibrosis. Medical Journal of Australia 162(1): 12-15

Hara, Y.; Ioannou, P.; Drousiotou, A.; Stylianidou, G.; Anastasiadou, V.; Suzuki, K. 1994: Mutation analysis of a Sandhoff disease patient in the Maronite community in Cyprus. Human Genetics 94(2): 136-140

Ibarreta, D.; Tao, J.; Parrilla, R.; Ayuso, M.S. 1997: Mutation analysis of chromosome 19 calmodulin (CALM3) gene in Alzheimer's disease patients. Neuroscience Letters 229(3): 157-160

Spotila, L.D.; Colige, A.; Sereda, L.; Constantinou-Deltas, C.D.; Whyte, M.P.; Riggs, B.L.; Shaker, J.L.; Spector, T.D.; Hume, E.; Olsen, N. 1994: Mutation analysis of coding sequences for type i procollagen in individuals with low bone density. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 9(6): 923-932

Geisel, J.; Gielen, J.; Oette, K.; Herrmann, W.; Wielckens, K. 1998: Mutation analysis of exon 3 of the LDL receptor gene in patients with severe hypercholesterolemia. Clinical Chemistry and Laboratory Medicine 36(5): 279-282

Ariga, T.; Yamada, M.; Sakiyama, Y. 1997: Mutation analysis of five Japanese families with Wiskott-Aldrich syndrome and determination of the family members' carrier status using three different methods. Pediatric Research 41(4 Part 1): 535-540

Dahia, P.L.; Toledo, S.P.; Mulligan, L.M.; Maher, E.R.; Grossman, A.B.; Eng, C. 1997: Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas. Cancer Research 57(2): 310-313

Marsh, D.J.; Zheng, Z.; Arnold, A.; Andrew, S.D.; Learoyd, D.; Frilling, A.; Komminoth, P.; Neumann, H.P.; Ponder, B.A.; Rollins, B.J.; Shapiro, G.I.; Robinson, B.G.; Mulligan, L.M.; Eng, C. 1997: Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 82(9): 3025-3028

Ichikawa, Y.; Yoshida, S.; Suzuki, H.; Nishida, M.; Tsunoda, H.; Kubo, T.; Miwa, M.; Uchida, K. 1996: Mutation analysis of gonadotropin receptor and G protein genes in various types of human ovarian tumors. Japanese Journal of Clinical Oncology 26(5): 298-302

Pereira, E.; Goldblatt, J.; Rye, P.; Sanderson, C.; Le Souëf, P. 1998: Mutation analysis of interleukin-5 in an asthmatic cohort. Human Mutation 11(1): 51-54

Oh, J.; Ho, L.; Ala-Mello, S.; Amato, D.; Armstrong, L.; Bellucci, S.; Carakushansky, G.; Ellis, J.P.; Fong, C.T.; Green, J.S.; Heon, E.; Legius, E.; Levin, A.V.; Nieuwenhuis, H.K.; Pinckers, A.; Tamura, N.; Whiteford, M.L.; Yamasaki, H.; Spritz, R.A. 1998: Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. American Journal of Human Genetics 62(3): 593-598

Kwok, C.; Tyler-Smith, C.; Mendonca, B.B.; Hughes, I.; Berkovitz, G.D.; Goodfellow, P.N.; Hawkins, J.R. 1996: Mutation analysis of the 2 kb 5' to SRY in XY females and XY intersex subjects. Journal of Medical Genetics 33(6): 465-468

Liu, T.T.; Hsiao, K.J.; Lu, S.F.; Wu, S.J.; Wu, K.F.; Chiang, S.H.; Liu, X.Q.; Chen, R.G.; Yu, W.M. 1998: Mutation analysis of the 6-pyruvoyl-tetrahydropterin synthase gene in Chinese hyperphenylalaninemia caused by tetrahydrobiopterin synthesis deficiency. Human Mutation 11(1): 76-83

Durocher, F.; Tonin, P.; Shattuck-Eidens, D.; Skolnick, M.; Narod, S.A.; Simard, J. 1996: Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. Journal of Medical Genetics 33(10): 814-819

Matsushima, M.; Kobayashi, K.; Emi, M.; Saito, H.; Saito, J.; Suzumori, K.; Nakamura, Y. 1995: Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Human Molecular Genetics 4(10): 1953-1956

Takahashi, H.; Behbakht, K.; McGovern, P.E.; Chiu, H.C.; Couch, F.J.; Weber, B.L.; Friedman, L.S.; King, M.C.; Furusato, M.; LiVolsi, V.A. 1995: Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Research 55(14): 2998-3002

de Weers, M.; Mensink, R.G.; Kraakman, M.E.; Schuurman, R.K.; Hendriks, R.W. 1994: Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Human Molecular Genetics 3(1): 161-166

Neuhaus, J.M.; Pietrzak, M.; Boller, T. 1994: Mutation analysis of the C-terminal vacuolar targeting peptide of tobacco chitinase: low specificity of the sorting system, and gradual transition between intracellular retention and secretion into the extracellular space. Plant Journal: for Cell and Molecular Biology 5(1): 45-54

Castilho-Valavicius, B.; Thompson, G.M.; Donahue, T.F. 1992: Mutation analysis of the Cys-X2-Cys-X19-Cys-X2-Cys motif in the beta subunit of eukaryotic translation initiation factor 2. Gene Expression 2(3): 297-309

Verlander, P.C.; Lin, J.D.; Udono, M.U.; Zhang, Q.; Gibson, R.A.; Mathew, C.G.; Auerbach, A.D. 1994: Mutation analysis of the Fanconi anemia gene FACC. American journal of human genetics 54(4): 595-601

Monaghan, K.G.; Rybicki, B.A.; Shurafa, M.; Feldman, G.L. 1998: Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. American Journal of Hematology 58(3): 213-217

Mercier, G.; Burckel, A.; Bathelier, C.; Boillat, E.; Lucotte, G. 1998: Mutation analysis of the HLA-H gene in French hemochromatosis patients, and genetic counseling in families. Genetic Counseling 9(3): 181-186

Carella, M.; D'Ambrosio, L.; Totaro, A.; Grifa, A.; Valentino, M.A.; Piperno, A.; Girelli, D.; Roetto, A.; Franco, B.; Gasparini, P.; Camaschella, C. 1997: Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. American Journal of Human Genetics 60(4): 828-832

Narayanan, V.; Olinsky, S.; Dahle, E.; Naidu, S.; Zoghbi, H.Y. 1998: Mutation analysis of the M6b gene in patients with Rett syndrome. American Journal of Medical Genetics 78(2): 165-168

Teh, B.T.; Kytölä, S.; Farnebo, F.; Bergman, L.; Wong, F.K.; Weber, G.; Hayward, N.; Larsson, C.; Skogseid, B.; Beckers, A.; Phelan, C.; Edwards, M.; Epstein, M.; Alford, F.; Hurley, D.; Grimmond, S.; Silins, G.; Walters, M.; Stewart, C.; Cardinal, J.; Khodaei, S.; Parente, F.; Tranebjaerg, L.; Jorde, R.; Salmela, P. 1998: Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 83(8): 2621-2626

Wissinger, B.; Besch, D.; Baumann, B.; Fauser, S.; Christ-Adler, M.; Jurklies, B.; Zrenner, E.; Leo-Kottler, B. 1997: Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy. Biochemical and Biophysical Research Communications 234(2): 511-515

Landsvater, R.M.; Jansen, R.P.; Hofstra, R.M.; Buys, C.H.; Lips, C.J.; Ploos van Amstel, H.K. 1996: Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: Two novel mutations and one de novo mutation for MEN 2A. Human Genetics 97(1): 11-14

Angrist, M.; Bolk, S.; Thiel, B.; Puffenberger, E.G.; Hofstra, R.M.; Buys, C.H.; Cass, D.T.; Chakravarti, A. 1995: Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Human Molecular Genetics 4(5): 821-830

Bascom, R.A.; Liu, L.; Heckenlively, J.R.; Stone, E.M.; McInnes, R.R. 1995: Mutation analysis of the ROM1 gene in retinitis pigmentosa. Human Molecular Genetics 4(10): 1895-1902

Takenoshita, S.; Tani, M.; Mogi, A.; Nagashima, M.; Nagamachi, Y.; Bennett, W.P.; Hagiwara, K.; Harris, C.C.; Yokota, J. 1998: Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis 19(5): 803-807

Futreal, P.A.; Cochran, C.; Marks, J.R.; Iglehart, J.D.; Zimmerman, W.; Barrett, J.C.; Wiseman, R.W. 1994: Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. Cancer Research 54(7): 1791-1794

Kumar, A.; Kandt, R.S.; Wolpert, C.; Roses, A.D.; Pericak-Vance, M.A.; Gilbert, J.R. 1995: Mutation analysis of the TSC2 gene in an African-American family. Human Molecular Genetics 4(12): 2295-2298

Hosoya, N.; Miyagawa, K.; Mitani, K.; Yazaki, Y.; Hirai, H. 1998: Mutation analysis of the WT1 gene in myelodysplastic syndromes. Japanese Journal of Cancer Research: Gann 89(8): 821-824

Goldstein, M.A.; Doi, R.H. 1994: Mutation analysis of the cellulose-binding domain of the Clostridium cellulovorans cellulose-binding protein A. Journal of Bacteriology 176(23): 7328-7334

Cruts, M.; Backhovens, H.; Van Gassen, G.; Theuns, J.; Wang, S.Y.; Wehnert, A.; van Duijn, C.M.; Karlsson, T.; Hofman, A.; Adolfsson, R. 1995: Mutation analysis of the chromosome 14q24.3 dihydrolipoyl succinyltransferase (DLST) gene in patients with early-onset Alzheimer disease. Neuroscience Letters 199(1): 73-77

Bansal, A.; Ramirez, R.D.; Minna, J.D. 1997: Mutation analysis of the coding sequences of MEK-1 and MEK-2 gene in human lung cancer cell lines. Oncogene 14(10): 1231-1234

Grebe, T.A.; Doane, W.W.; Richter, S.F.; Clericuzio, C.; Norman, R.A.; Seltzer, W.K.; Rhodes, S.N.; Goldberg, B.E.; Hernried, L.S.; McClure, M. 1992: Mutation analysis of the cystic fibrosis transmembrane regulator gene in Native American populations of the southwest. American Journal of Human Genetics 51(4): 736-740

Wartiovaara, K.; Hytönen, M.; Vuori, M.; Paulin, L.; Rinne, J.; Sariola, H. 1998: Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease. Experimental Neurology 152(2): 307-309

Layman, L.C.; Peak, D.B.; Xie, J.; Son, S.H.; Reindollar, R.H.; Gray, M.R. 1997: Mutation analysis of the gonadotropin-releasing hormone receptor gene in idiopathic hypogonadotropic hypogonadism. Fertility and Sterility 68(6): 1079-1085,.

Eklund, L.K.; Lindström, E.; Undén, A.B.; Lundh-Rozell, B.; Ståhle-Bäckdahl, M.; Zaphiropoulos, P.G.; Toftgård, R.; Söderkvist, P. 1998: Mutation analysis of the human homologue of Drosophila patched and the xeroderma pigmentosum complementation group A genes in squamous cell carcinomas of the skin. Molecular Carcinogenesis 21(2): 87-92

Beuten, J.; De Vriendt, E.; De Jonghe, P.; Martin, J.J.; Van Broeckhoven, C.; Timmerman, V. 1997: Mutation analysis of the human pancreatic phospholipase A2 gene in a family with distal hereditary motor neuropathy type II linked to 12q24. Neuroscience Letters 223(1): 69-71

Nelis, E.; De Jonghe, P.; De Vriendt, E.; Patel, P.I.; Martin, J.J.; Van Broeckhoven, C. 1998: Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1 disease and HNPP. Journal of Medical Genetics 35(7): 590-593

González, M.V.; Artímez, M.L.; Rodrigo, L.; López-Larrea, C.; Menéndez, M.J.; Alvarez, V.; Pérez, R.; Fresno, M.F.; Pérez, M.J.; Sampedro, A.; Coto, E. 1997: Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. Journal of Clinical Pathology 50(3): 212-217

Tyfield, L.A.; Stephenson, A.; Bidwell, J.L.; Wood, N.A.; Cockburn, F.; Harvie, A.; Smith, I. 1994: Mutation analysis of the phenylalanine hydroxylase gene using heteroduplex analysis with synthetic DNA constructs. Acta Paediatrica . Suppl 407: 47-48

Yokomizo, A.; Tindall, D.J.; Hartmann, L.; Jenkins, R.B.; Smith, D.I.; Liu, W. 1998: Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer. International Journal of Oncology 13(1): 101-105

Rhei, E.; Kang, L.; Bogomolniy, F.; Federici, M.G.; Borgen, P.I.; Boyd, J. 1997: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Research 57(17): 3657-3659

Tierens, A.; Delabie, J.; Pittaluga, S.; Driessen, A.; DeWolf-Peeters, C. 1998: Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 91(7): 2381-2386

Nishizawa, K.; Okamoto, H. 1994: Mutation analysis of the role for the carboxy-terminus encoding region in NGF-induced stabilization of GAP-43 mRNA. Biochemical and Biophysical Research Communications 205(2): 1380-1385

Kim, S.K.; Makino, K.; Amemura, M.; Nakata, A.; Shinagawa, H. 1995: Mutational analysis of the role of the first helix of region 4.2 of the sigma 70 subunit of Escherichia coli RNA polymerase in transcriptional activation by activator protein PhoB. Molecular and General Genetics: Mgg 248(1): 1-8

Vincent, F.; Hagiwara, K.; Ke, Y.; Stoner, G.D.; Demetrick, D.J.; Bennett, W.P. 1996: Mutation analysis of the transforming growth factor beta type Ii receptor in sporadic human cancers of the pancreas, liver, and breast. Biochemical and Biophysical Research Communications 223(3): 561-564

Ke, Y.; Hagiwara, K.; Su, X. 1997: Mutation analysis of transforming growth factor-beta type II receptor gene in human gastric cancer tissues. Zhonghua Zhong Liu Za Zhi 19(1): 25-27

Reed, V.; Boyd, Y. 1997: Mutation analysis provides additional proof that mottled is the mouse homologue of Menkes' disease. Human Molecular Genetics 6(3): 417-423

Kotze, M.J.; Thiart, R.; Loubser, O.; de Villiers, J.N.; Santos, M.; Vargas, M.A.; Peeters, A.V. 1996: Mutation analysis reveals an insertional hotspot in exon 4 of the LDL receptor gene. Human Genetics 98(4): 476-478

Jenkins, G.J.; Chaleshtori, M.H.; Song, H.; Parry, J.M. 1998: Mutation analysis using the restriction site mutation (RSM) assay. Mutation Research 405(2): 209-220

Kihana, T.; Hamada, K.; Inoue, Y.; Yano, N.; Iketani, H.; Murao, S.; Ukita, M.; Matsuura, S. 1995: Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients. Cancer 76(1): 72-78

Jones, R.F.; Matuszyk, J.; Debiec-Rychter, M.; Wang, C.Y. 1994: Mutation and altered expression of p53 genes in experimental rat bladder tumor cells. Molecular Carcinogenesis 9(2): 95-104

Wang, D.; Song, H.; Evans, J.A.; Lang, J.C.; Schuller, D.E.; Weghorst, C.M. 1997: Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18(11): 2285-2290

Schug, M.D.; Hutter, C.M.; Noor, M.A.; Aquadro, C.F. 1998: Mutation and evolution of microsatellites in Drosophila melanogaster. Genetica 102-103(1-6): 359-367

Dieterich, K.D.; Gundelfinger, E.D.; Lüdecke, D.K.; Lehnert, H. 1998: Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 83(9): 3327-3331

Takeuchi, S.; Koeffler, H.P.; Hinton, D.R.; Miyoshi, I.; Melmed, S.; Shimon, I. 1998: Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors. Journal of Endocrinology 157(2): 337-341

Gallione, C.J.; Klaus, D.J.; Yeh, E.Y.; Stenzel, T.T.; Xue, Y.; Anthony, K.B.; McAllister, K.A.; Baldwin, M.A.; Berg, J.N.; Lux, A.; Smith, J.D.; Vary, C.P.; Craigen, W.J.; Westermann, C.J.; Warner, M.L.; Miller, Y.E.; Jackson, C.E.; Guttmacher, A.E.; Marchuk, D.A. 1998: Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Human Mutation 11(4): 286-294

Cleaver, J.E.; McDowell, M.; Jones, C.; Wood, R.; Karentz, D. 1994: Mutation and expression of the XPA gene in revertants and hybrids of a xeroderma pigmentosum cell line. Somatic Cell and Molecular Genetics 20(4): 327-337

Papandreou, C.; Bogenrieder, T.; Loganzo, F.; Chao, M.V.; Nanus, D.M.; Albino, A.P. 1996: Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma. Melanoma Research 6(5): 373-378

Weiss, J.; Schwechheimer, K.; Cavenee, W.K.; Herlyn, M.; Arden, K.C. 1993: Mutation and expression of the p53 gene in malignant melanoma cell lines. International Journal of Cancer 54(4): 693-699

Matsumoto, T.; Imamura, O.; Yamabe, Y.; Kuromitsu, J.; Tokutake, Y.; Shimamoto, A.; Suzuki, N.; Satoh, M.; Kitao, S.; Ichikawa, K.; Kataoka, H.; Sugawara, K.; Thomas, W.; Mason, B.; Tsuchihashi, Z.; Drayna, D.; Sugawara, M.; Sugimoto, M.; Furuichi, Y.; Goto, M. 1997: Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: Genetic epidemiology in the Japanese population. Human Genetics 100(1): 123-130

Kozák, L.; Blazková, M.; Kuhrová, V.; Pijácková, A.; Růzicková, S.; St'astná, S. 1997: Mutation and haplotype analysis of phenylalanine hydroxylase alleles in classical PKU patients from the Czech Republic: identification of four novel mutations. Journal of Medical Genetics 34(11): 893-898

Varon, M.; Fuchs, N.; Monosov, M.; Tolchinsky, S.; Rosenberg, E. 1992: Mutation and mapping of genes involved in production of the antibiotic TA in Myxococcus xanthus. Antimicrobial Agents and ChemoTherapy 36(10): 2316-2321

Uchida, T.; Wang, C.; Sato, T.; Muramoto, M.; Iwamura, M.; Egawa, S.; Koshiba, K. 1997: Mutation and microsatellite instability analysis of the androgen receptor gene in human prostate cancer. International Journal of Oncology 11(3): 551-556

Ewaskow, S.P.; Sidorova, J.M.; Hendle, J.; Emery, J.C.; Lycan, D.E.; Zhang, K.Y.; Breeden, L.L. 1998: Mutation and modeling analysis of the Saccharomyces cerevisiae Swi6 ankyrin repeats. Biochemistry 37(13): 4437-4450

Cha, M.K.; Kim, H.K.; Kim, I.H. 1996: Mutation and Mutagenesis of thiol peroxidase of Escherichia coli and a new type of thiol peroxidase family. Journal of Bacteriology 178(19): 5610-5614

Kohler, M.F.; Kerns, B.J.M.; Humphrey, P.A.; Marks, J.A.; BastRobert, C.Jr.; Berchuck, A. 1993: Mutation and overexpression of p53 in early-stage epithelial ovarian cell. Obstetrics and Gynecology 81(5 Part 1): 643-650

Liu, F.S.; Kohler, M.F.; Marks, J.R.; Bast, R.C.; Boyd, J.; Berchuck, A. 1994: Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstetrics and Gynecology 83(1): 118-124

Lee, H.C.; Wei, Y.H. 1997: Mutation and oxidative damage of mitochondrial DNA and defective turnover of mitochondria in human aging. Journal of the Formosan Medical Association 96(10): 770-778

Cornea, R.L.; Jones, L.R.; Autry, J.M.; Thomas, D.D. 1997: Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 36(10): 2960-2967

Kure, S.; Sakata, Y.; Miyabayashi, S.; Takahashi, K.; Shinka, T.; Matsubara, Y.; Hoshino, H.; Narisawa, K. 1998: Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy. Journal of Human Genetics 43(2): 128-131

Beltrán-Valero de Bernabé, D.; Granadino, B.; Chiarelli, I.; Porfirio, B.; Mayatepek, E.; Aquaron, R.; Moore, M.M.; Festen, J.J.; Sanmartí, R.; Peñalva, M.A.; de Córdoba, S.R. 1998: Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients. American Journal of Human Genetics 62(4): 776-784

Zhang, X.; Sun; Kailai; Jiang; Li 1992: Mutation and polymorphism of the phenylalanine hydroxylase gene detected by PCR-SSCP analysis. Journal of China Medical University 21(3): 169-171

Gabizon, R.; Rosenmann, H.; Meiner, Z.; Kahana, I.; Kahana, E.; Shugart, Y.; Ott, J.; Prusiner, S.B. 1993: Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). American Journal of Human Genetics 53(4): 828-835

Nakamura, H.; Said, J.W.; Miller, C.W.; Koeffler, H.P. 1993: Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 82(3): 920-926

Rand, D.M.; Kann, L.M. 1998: Mutation and selection at silent and replacement sites in the evolution of animal mitochondrial DNA. Genetica 102-103(1-6): 393-407

Promislow, D.E.; Tatar, M. 1998: Mutation and senescence: Where genetics and demography meet. Genetica 102-103(1-6): 299-314

Bonhoeffer, S.; Nowak, M.A. 1994: Mutation and the evolution of virulence. Proceedings of the Royal Society of London Series B Biological Sciences 258(1352): 133-140

Mangasarian, K.; Li, Y.; Mansukhani, A.; Basilico, C. 1997: Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. Journal of Cellular Physiology 172(1): 117-125

Madern, D.; Pfister, C.; Zaccai, G. 1995: Mutation at a single acidic amino acid enhances the halophilic behaviour of malate dehydrogenase from Haloarcula marismortui in physiological salts. European Journal of Biochemistry 230(3): 1088-1095

Koreth, J.; Bethwaite, P.B.; McGee, J.O. 1995: Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. Journal of Pathology 176(1): 11-18

Kar, S.; Jaffe, R.; Carr, B.I. 1993: Mutation at codon 249 of p53 gene in a human hepatoblastoma. Hepatology 18(3): 566-569

Bartels, C.F.; Zelinski, T.; Lockridge, O. 1993: Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. American Journal of Human Genetics 52(5): 928-936

Amano, K.; Michnick, D.A.; Moussalli, M.; Kaufman, R.J. 1998: Mutation at either Arg336 or Arg562 in factor VIII is insufficient for complete resistance to activated protein C (APC)-mediated inactivation: implications for the APC resistance test. Thrombosis and Haemostasis 79(3): 557-563

Hodgkinson, C.A.; Nakayama, A.; Li, H.; Swenson, L.B.; Opdecamp, K.; Asher, J.H.; Arnheiter, H.; Glaser, T. 1998: Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2. Human Molecular Genetics 7(4): 703-708

Fujimori, A.; Harker, W.G.; Kohlhagen, G.; Hoki, Y.; Pommier, Y. 1995: Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Research 55(6): 1339-1346

Fournier, E.; Dubreuil, P.; Birnbaum, D.; Borg, J.P. 1995: Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 11(5): 921-931

Onel, K.; Thelen, M.P.; Ferguson, D.O.; Bennett, R.L.; Holloman, W.K. 1995: Mutation avoidance and DNA repair proficiency in Ustilago maydis are differentially lost with progressive truncation of the REC1 gene product. Molecular and Cellular Biology 15(10): 5329-5338

Reddy, V.R.K.; Suganthi, C.P.; Edwin, R. 1994: Mutation breeding in some cereals: III. Mutagenic parameters. Advances in Plant Sciences 7(2): 323-329

Suganthi, C.P.; Reddy, V.R.K.; Edwin, R. 1994: Mutation breeding in some cereals: IV. Biological parameters. Advances in Plant Sciences 7(1): 1-11

Johnston, J.; Kelley, R.I.; Feigenbaum, A.; Cox, G.F.; Iyer, G.S.; Funanage, V.L.; Proujansky, R. 1997: Mutation characterization and genotype-phenotype correlation in Barth syndrome. American Journal of Human Genetics 61(5): 1053-1058

Berg, M.A.; Guevara-Aguirre, J.; Rosenbloom, A.L.; Rosenfeld, R.G.; Francke, U. 1992: Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Human Mutation 1(1): 24-32

Schwartz, H.; Alvares, C.P.; White, M.B.; Fields, S. 1998: Mutation detection by a two-hybrid assay. Human Molecular Genetics 7(6): 1029-1032

Fodde, R.; Losekoot, M. 1994: Mutation detection by denaturing gradient gel electrophoresis (DGGE). Human Mutation 3(2): 83-94

Kovach, J.S.; Hartmann, A.; Blaszyk, H.; Cunningham, J.; Schaid, D.; Sommer, S.S. 1996: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proceedings of the National Academy of Sciences of the United States of America 93(3): 1093-1096

Lishanski, A.; Ostrander, E.A.; Rine, J. 1994: Mutation detection by mismatch binding protein, MutS, in amplified DNA: application to the cystic fibrosis gene. Proceedings of the National Academy of Sciences of the United States of America 91(7): 2674-2678

Hollway, G.E.; Suthers, G.K.; Haan, E.A.; Thompson, E.; David, D.J.; Gecz, J.; Mulley, J.C. 1997: Mutation detection in FGFR2 craniosynostosis syndromes. Human Genetics 99(2): 251-255

Lindblad, K.; Lunkes, A.; Maciel, P.; Stevanin, G.; Zander, C.; Klockgether, T.; Ratzlaff, T.; Brice, A.; Rouleau, G.A.; Hudson, T.; Auburger, G.; Schalling, M. 1996: Mutation detection in Machado-Joseph disease using repeat expansion detection. Molecular Medicine 2(1): 77-85

Bradley, L.A.; Sweatman, A.K.; Lovering, R.C.; Jones, A.M.; Morgan, G.; Levinsky, R.J.; Kinnon, C. 1994: Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Human Molecular Genetics 3(1): 79-83

Kohrman, D.C.; Harris, J.B.; Meisler, M.H. 1996: Mutation detection in the med and medJ alleles of the sodium channel Scn8a. Unusual splicing due to a minor class AT-AC intron. Journal of Biological Chemistry 271(29): 17576-17581

Roelfsema, J.H.; Spruit, L.; Saris, J.J.; Chang, P.; Pirson, Y.; van Ommen, G.J.; Peters, D.J.; Breuning, M.H. 1997: Mutation detection in the repeated part of the PKD1 gene. American Journal of Human Genetics 61(5): 1044-1052

Oleykowski, C.A.; Bronson Mullins, C.R.; Godwin, A.K.; Yeung, A.T. 1998: Mutation detection using a novel plant endonuclease. Nucleic Acids Research 26(20): 4597-4602

Wagner, R.; Debbie, P.; Radman, M. 1995: Mutation detection using immobilized mismatch binding protein (MutS). Nucleic Acids Research 23(19): 3944-3948

Smith, J.; Modrich, P. 1996: Mutation detection with MutH, MutL, and MutS mismatch repair proteins. Proceedings of the National Academy of Sciences of the United States of America 93(9): 4374-4379

Watanabe, K.; Ohta, T. 1993: Mutation enhancing effect of o-vanillin in the lacZ gene of Escherichia coli: Characterization of mutational spectrum. Mutation Research 302(1): 13-18

Mancuso, T.; Aguilar, F.; Pescarolo, M.P.; Clerico, L.; Russo, P.; Parodi, S. 1997: Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype. Nucleic Acids Research 25(18): 3643-3648

Lucotte, G.; Turpin, J.C.; Gérard, N.; Panserat, S.; Krishnamoorthy, R. 1996: Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. American Journal of Medical Genetics 67(4): 361-365

Karnaoukhova, L.; Moffat, J.; Martins, H.; Glickman, B. 1997: Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy. Cancer Research 57(19): 4393-4407

Li, B.H.; Bockrath, R. 1995: Mutation frequency decline in Escherichia coli. I. Effects of defects in mismatch repair. Molecular and General Genetics: Mgg 249(6): 585-590

Grzesiuk, E.; Janion, C. 1998: Mutation frequency decline in MMS-treated Escherichia coli K-12 mutS strains. Mutagenesis 13(2): 127-132

Akiyama, M.; Kyoizumi, S.; Hirai, Y.; Kusunoki, Y.; Iwamoto, K.S.; Nakamura, N. 1995: Mutation frequency in human blood cells increases with age. Mutation Research 338(1-6): 141-149

Tuerlings, J.H.; Mol, B.; Kremer, J.A.; Looman, M.; Meuleman, E.J.; te Meerman, G.J.; Buys, C.H.; Merkus, H.M.; Scheffer, H. 1998: Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection. Fertility and Sterility 69(5): 899-903

Guttler, F.; Guldberg, P.; Henriksen, K.F.iis 1993: Mutation genotype of mentally retarded patients with phenylketonuria. Developmental Brain Dysfunction 6(1-3): 92-96

Bienvenu, T.; Cazeneuve, C.; Kaplan, J.C.; Beldjord, C. 1995: Mutation heterogeneity of cystic fibrosis in France: screening by denaturing gradient gel electrophoresis using psoralen-modified oligonucleotide. Human Mutation 6(1): 23-29

Korvatska, E.; Munier, F.L.; Djemaï, A.; Wang, M.X.; Frueh, B.; Chiou, A.G.; Uffer, S.; Ballestrazzi, E.; Braunstein, R.E.; Forster, R.K.; Culbertson, W.W.; Boman, H.; Zografos, L.; Schorderet, D.F. 1998: Mutation hot spots in 5q31-linked corneal dystrophies. American Journal of Human Genetics 62(2): 320-324

Ziegler, A.; Leffell, D.J.; Kunala, S.; Sharma, H.W.; Gailani, M.; Simon, J.A.; Halperin, A.J.; Baden, H.P.; Shapiro, P.E.; Bale, A.E. 1993: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proceedings of the National Academy of Sciences of the United States of America 90(9): 4216-4220

Burwinkel, B.; Shin, Y.S.; Bakker, H.D.; Deutsch, J.; Lozano, M.J.; Maire, I.; Kilimann, M.W. 1996: Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). Human Molecular Genetics 5(5): 653-658

Mendonça, B.B.; Russell, A.J.; Vasconcelos-Leite, M.; Arnhold, I.J.; Bloise, W.; Wajchenberg, B.L.; Nicolau, W.; Sutcliffe, R.G.; Wallace, A.M. 1994: Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. Journal of Molecular Endocrinology 12(1): 119-122

Kantheti, P.; Qiao, X.; Diaz, M.E.; Peden, A.A.; Meyer, G.E.; Carskadon, S.L.; Kapfhamer, D.; Sufalko, D.; Robinson, M.S.; Noebels, J.L.; Burmeister, M. 1998: Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 21(1): 111-122

Tanaka, M.; Otsuki, M.; Nishino, T.; Kobayashi, I.; Matsumoto, T.; Kumazawa, J. 1996: Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae. Genitourinary Medicine 72(4): 295-297

Kokontis, J.M.; Tsung, S.S.; Vaughan-Johnson, J.; Lee, H.; Harvey, R.G.; Weiss, S.B. 1993: Mutation in Escherichia coli and mammalian cells induced by closely spaced 1-methylpyrene-deoxyadenosine adducts in opposite DNA strands. Carcinogenesis 14(4): 645-651

Bridges, B.A.; Timms, A.R. 1997: Mutation in Escherichia coli under starvation conditions: a new pathway leading to small deletions in strains defective in mismatch correction. EMBO Journal 16(11): 3349-3356

Tipples, G.A.; Ma, M.M.; Fischer, K.P.; Bain, V.G.; Kneteman, N.M.; Tyrrell, D.L. 1996: Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24(3): 714-717

Takahashi, Y.; Tahira, T.; Nakamura, H.; Uno, M.; Tanaka, T.; Ono, Y. 1992: Mutation in IgH gene of the Epstein-Barr virus-transformed pro-B cells FLEB14 selected for low serum-dependency. Nichidai Igaku Zasshi 51(11-12): 983-992

Formisano, P.; Sohn, K.J.; Miele, C.; Di Finizio, B.; Petruzziello, A.; Riccardi, G.; Beguinot, L.; Beguinot, F. 1993: Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action. Journal of Biological Chemistry 268(7): 5241-5248

Boguta, M.; Czerska, K.; Zoładek, T. 1997: Mutation in a new gene MAF1 affects tRNA suppressor efficiency in Saccharomyces cerevisiae. Gene 185(2): 291-296

Hihara, Y.kako; Ikeuchi, Masahiko 1997: Mutation in a novel gene required for photomixotrophic growth leads to enhanced photoautotrophic growth of Synechocystis sp. PCC 6803. Photosynthesis Research 53(2-3): 243-252

Pomponio, R.J.; Yamaguchi, A.; Arashima, S.; Hymes, J.; Wolf, B. 1998: Mutation in a putative glycosylation site (N489T) of biotinidase in the only known Japanese child with biotinidase deficiency. Molecular Genetics and Metabolism 64(2): 152-154

Varesco, L.; Gismondi, V.; Presciuttini, S.; Groden, J.; Spirio, L.; Sala, P.; Rossetti, C.; De Benedetti, L.; Bafico, A.; Heouaine, A. 1994: Mutation in a splice-donor site of the APC gene in a family with polyposis and late age of colonic cancer death. Human Genetics 93(3): 281-286

Tamura, H.; Tameishi, K.; Yamada, A.; Tomita, M.; Matsuo, Y.; Nishikawa, K.; Ikezawa, H. 1995: Mutation in aspartic acid residues modifies catalytic and haemolytic activities of Bacillus cereus sphingomyelinase. Biochemical Journal 309: 757-764

Gabizon, R.; Rosenman, H.; Meiner, Z.; Kahana, I.; Kahana, E.; Shugart, Y.; Ott, J.; Prusiner, S.B. 1994: Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 343(1306): 385-390

Beck, R.; Crooke, H.; Jarsch, M.; Cole, J.; Burtscher, H. 1994: Mutation in dipZ leads to reduced production of active human placental alkaline phosphatase in Escherichia coli. Fems Microbiology Letters 124(2): 209-214

Zinchenko, V.; Babykin, M.; Glaser, V.; Mekhedov, S.; Shestakov, S. 1997: Mutation in ntrC gene leading to the derepression of nitrogenase synthesis in Rhodobacter sphaeroides. Fems Microbiology Letters 147(1): 57-61

Iijima, M.; Mihara, K.; Kondo, T.; Tsuji, T.; Ishioka, C.; Namba, M. 1996: Mutation in p53 and de-regulation of p53-related gene expression in three human cell lines immortalized with 4-nitroquinoline 1-oxide or 60Co gamma rays. International Journal of Cancer 66(5): 698-702

Hirano, K.; Takahashi, M.; Kazumi, Y.; Fukasawa, Y.; Abe, C. 1998: Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle and Lung Disease 78(2): 117-122

Chou, S.; Marousek, G.; Parenti, D.M.; Gordon, S.M.; LaVoy, A.G.; Ross, J.G.; Miner, R.C.; Drew, W.L. 1998: Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. Journal of Infectious Diseases 178(2): 526-530

Arnaud, J.; Cayrou, C.; Llobera, R.; Rubin, B. 1997: Mutation in splicing consensus sequences causes lack of TCR membrane expression due to exon excision. Immunogenetics 45(5): 311-319

Sandford, A.J.; Spinelli, J.J.; Weir, T.D.; Paré, P.D. 1997: Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. Journal of Medical Genetics 34(10): 874-875

Citron, B.A.; Kaufman, S.; Milstien, S.; Naylor, E.W.; Greene, C.L.; Davis, M.D. 1993: Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. American Journal of Human Genetics 53(3): 768-774

Tenney, D.J.; Micheletti, P.A.; Stevens, J.T.; Hamatake, R.K.; Matthews, J.T.; Sanchez, A.R.; Hurlburt, W.W.; Bifano, M.; Cordingley, M.G. 1993: Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity. Journal of Virology 67(1): 543-547

Freisinger, P.; Ala-Kokko, L.; LeGuellec, D.; Franc, S.; Bouvier, R.; Ritvaniemi, P.; Prockop, D.J.; Bonaventure, J. 1994: Mutation in the COL2A1 gene in a patient with hypochondrogenesis. Expression of mutated COL2A1 gene is accompanied by expression of genes for type I procollagen in chondrocytes. Journal of Biological Chemistry 269(18): 13663-13669

Vazquez de Aldana, C.R.; Hinnebusch, A.G. 1994: Mutations in the GCD7 subunit of yeast guanine nucleotide exchange factor eIF-2B overcome the inhibitory effects of phosphorylated eIF-2 on translation initiation. Molecular and Cellular Biology 14(5): 3208-3222

Luo, H.; Rose, P.; Barber, D.; Hanratty, W.P.; Lee, S.; Roberts, T.M.; D'Andrea, A.D.; Dearolf, C.R. 1997: Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Molecular and Cellular Biology 17(3): 1562-1571

Pickard, M.; Sherrington, P.; Brett, M.; Green, B.; Howelevans, A.; Smith, D.; Poston, G.; Kinsella, A. 1996: Mutation in the K-ras gene at codon 12 does not correlate with disease progression in colorectal carcinoma patients treated with 5-FU/folinic acid biomodulated chemotherapy. International Journal of Oncology 9(6): 1301-1306

Wang, H.L.; Auerbach, A.; Bren, N.; Ohno, K.; Engel, A.G.; Sine, S.M. 1997: Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. Journal of General Physiology 109(6): 757-766

Kulak, S.C.; Kozlowski, K.; Semina, E.V.; Pearce, W.G.; Walter, M.A. 1998: Mutation in the RIEG1 gene in patients with iridogoniodysgenesis syndrome. Human Molecular Genetics 7(7): 1113-1117

Sansone, V.; Rotondo, G.; Ptacek, L.J.; Meola, G. 1994: Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family. Italian Journal of Neurological Sciences 15(9): 473-480

Kennedy, B.K.; Austriaco, N.R.; Zhang, J.; Guarente, L. 1995: Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 80(3): 485-496

Lurain, N.S.; Spafford, L.E.; Thompson, K.D. 1994: Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. Journal of Virology 68(7): 4427-4431

Higuchi, S.; Arai, H.; Matsushita, S.; Matsui, T.; Kimpara, T.; Takeda, A.; Shirakura, K. 1998: Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies. Experimental Neurology 153(1): 164-166

Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; Di Iorio, G.; Golbe, L.I.; Nussbaum, R.L. 1997: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276(5321): 2045-2047

Denison, S.H.; Käfer, E.; May, G.S. 1993: Mutation in the bimD gene of Aspergillus nidulans confers a conditional mitotic block and sensitivity to DNA damaging agents. Genetics 134(4): 1085-1096

Novials, A.; Vidal, J.; Franco, C.; Ribera, F.; Sener, A.; Malaisse, W.J.; Gomis, R. 1997: Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochemical and Biophysical Research Communications 231(3): 570-572

Tomie, Y.; Horie, Y.; Tajima, F.; Kitaoka, S.; Nanba, E.; Yuasa, I.; Kawasaki, H. 1998: Mutation in the exon 10 (R173W) of the hydroxymethylbilane synthase gene in two unrelated Japanese families with acute intermittent porphyria. Research Communications in Molecular Pathology and Pharmacology 99(1): 5-15

Aittomäki, K.; Lucena, J.L.; Pakarinen, P.; Sistonen, P.; Tapanainen, J.; Gromoll, J.; Kaskikari, R.; Sankila, E.M.; Lehväslaiho, H.; Engel, A.R.; Nieschlag, E.; Huhtaniemi, I.; de la Chapelle, A. 1995: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82(6): 959-968

Ridker, P.M.; Hennekens, C.H.; Lindpaintner, K.; Stampfer, M.J.; Eisenberg, P.R.; Miletich, J.P. 1995: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New England Journal of Medicine 332(14): 912-917

Yang, S.W.; Kitoh, H.; Yamada, Y.; Goto, H.; Ogasawara, N. 1998: Mutation in the gene encoding the fibroblast growth factor receptor-3 in Korean children with achondroplasia. Acta Paediatrica Japonica: Overseas Edition 40(4): 324-327

Vila, J.; Ruiz, J.; Goñi, P.; Marcos, A.; Jimenez de Anta, T. 1995: Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and ChemoTherapy 39(5): 1201-1203

Chou, Y.H.; Pollak, M.R.; Brandi, M.L.; Toss, G.; Arnqvist, H.; Atkinson, A.B.; Papapoulos, S.E.; Marx, S.; Brown, E.M.; Seidman, J.G. 1995: Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. American Journal of Human Genetics 56(5): 1075-1079

Razaka-Jolly, D.; Rigoulet, M.; Guérin, B.; Velours, J. 1994: Mutation in the hydrophobic domain of ATP synthase subunit 4 (subunit b) of yeast mitochondria disturbs coupling between proton translocation and catalysis. Biochemistry 33(32): 9684-9691

McKimm-Breschkin, J.L.; McDonald, M.; Blick, T.J.; Colman, P.M. 1996: Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 225(1): 240-242

Luo, G.X.; Hua, S.; Horowitz, P.M. 1995: Mutation in the interdomain tether influences the stability and refolding of the enzyme rhodanese. Biochimica Et Biophysica Acta 1252(1): 165-171

Doré, B.T.; Momparler, R.L. 1996: Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs. Leukemia Research 20(9): 761-769

Sekler, M.S.; Simoni, R.D. 1995: Mutation in the lumenal part of the membrane domain of HMG-CoA reductase alters its regulated degradation. Biochemical and Biophysical Research Communications 206(1): 186-193

Pandya, A.; Xia, X.; Radnaabazar, J.; Batsuuri, J.; Dangaansuren, B.; Fischel-Ghodsian, N.; Nance, W.E. 1997: Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. Journal of Medical Genetics 34(2): 169-172

Hoshida, M.; Honda, M.; Kawano, S.I.; Fujimori, S. 1996: Mutation in the mitochondrial gene in a case of diabetic retinopathy. Rinsho Ganka 50(5): 827-830

Yanagisawa, K.; Uchigata, Y.; Sanaka, M.; Sakura, H.; Minei, S.; Shimizu, M.; Kanamuro, R.; Kadowaki, T.; Omori, Y. 1995: Mutation in the mitochondrial tRNA(leu) at position 3243 and spontaneous abortions in Japanese women attending a clinic for diabetic pregnancies. Diabetologia 38(7): 809-815

Sokol, L.; Prchal, J.F.; D'Andrea, A.; Rado, T.A.; Prchal, J.T. 1994: Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Experimental Hematology 22(5): 447-453

Flagiello, L.; Cirigliano, V.; Strazzullo, M.; Cappa, V.; Ciccodicola, A.; D'esposito, M.; Torrente, I.; Werner, R.; Di-Iorio, G.; Rinaldi, M.; Dallapiccola, B.; Forabosco, A.; Ventruto, V.; D'urso, M. 1998: Mutation in the nerve-specific 5' non-coding region of Cx32 gene and absence of specific mRNA in a CMTX1 Italian family. Human Mutation 12(5): 361

Wang, L.; Patel, U.; Ghosh, L.; Chen, H.C.; Banerjee, S. 1993: Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Research 53(4): 717-720

Pei, Z.; Burucoa, C.; Grignon, B.; Baqar, S.; Huang, X.Z.; Kopecko, D.J.; Bourgeois, A.L.; Fauchere, J.L.; Blaser, M.J. 1998: Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infection and Immunity 66(3): 938-943

Bailey, C.H.; Kaang, B.K.; Chen, M.; Martin, K.C.; Lim, C.S.; Casadio, A.; Kandel, E.R. 1997: Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons. Neuron 18(6): 913-924

Bidnenko, V.E.; Gruss, A.; Ehrlich, S.D. 1993: Mutation in the plasmid pUB110 Rep protein affects termination of rolling circle replication. Journal of Bacteriology 175(17): 5611-5616

Hoque, M.Z.; Kitamoto, T.; Furukawa, H.; Muramoto, T.; Tateishi, J. 1996: Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: A clinicopathological, immunohistochemical and transmission study. Acta Neuropathologica 92(5): 441-446

Kobielak, K.; Kobielak, A.; Limon, J.; Trzeciak, W.H. 1998: Mutation in the regulatory region of the EDA gene coincides with the symptoms of anhidrotic ectodermal dysplasia. Acta Biochimica Polonica 45(1): 245-250

Dorman, S.E.; Holland, S.M. 1998: Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. Journal of Clinical Investigation 101(11): 2364-2369

Olafsson, O.; Ericson, J.U.; VanBogelen, R.; Björk, G.R. 1996: Mutation in the structural gene for release factor 1 (RF-1) of Salmonella typhimurium inhibits cell division. Journal of Bacteriology 178(13): 3829-3839

Spillantini, M.G.; Murrell, J.R.; Goedert, M.; Farlow, M.R.; Klug, A.; Ghetti, B. 1998: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences of the United States of America 95(13): 7737-7741

Vahava, O.; Morell, R.; Lynch, E.D.; Weiss, S.; Kagan, M.E.; Ahituv, N.; Morrow, J.E.; Lee, M.K.; Skvorak, A.B.; Morton, C.C.; Blumenfeld, A.; Frydman, M.; Friedman, T.B.; King, M.C.; Avraham, K.B. 1998: Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 279(5358): 1950-1954

Wójcik, A.; Janion, C. 1997: Mutation induction and mutation frequency decline in halogen light-irradiated Escherichia coli K-12 AB1157 strains. Mutation Research 390(1-2): 85-92

Zöhrer, E.; Albertini, S.; Gocke, E.; Knasmüller, S. 1996: Mutation induction and mutation spectra of S. typhimurium TA100 after exposure to isohistidines. Mutation Research 356(2): 155-161

Tasseron-de Jong, J.G.; den Dulk, H.; Lichtenauer-Kaligis, E.G.; Kroone, R.C.; Giphart-Gassler, M.; van de Putte, P. 1993: Mutation induction by UV light in retroviral hprt cDNA integrated at various chromosomal positions in repair-deficient hamster cells. Mutagenesis 8(5): 399-406

Kozubek, S.; Rýznar, L.; Horneck, G. 1994: Mutation induction by accelerated heavy ions in bacteria. Mutation Research 309(1): 17-28

Furuno-Fukushi, I.; Aoki, K.; Matsudaira, H. 1993: Mutation induction by different dose rates of gamma rays in near-diploid mouse cells in plateau- and log-phase culture. Radiation Research 136(1): 97-102

Toya, K.; Shigematsu, N.; Ito, H.; Yamashita, S.; Kubo, A.; Kanai, T. 1996: Mutation induction by heavy ion beams and X-rays: analysis with cultured cell line. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 56(11): 736-740

Kent, C.R.; Edwards, S.M.; McMillan, T.J. 1993: Mutation induction by ionizing radiation in three human bladder tumour cell lines. International Journal of Radiation Biology 63(1): 1-5

Suzuki, K.; Hei, T.K. 1996: Mutation induction in gamma-irradiated primary human bronchial epithelial cells and molecular analysis of the HPRT- mutants. Mutation Research 349(1): 33-41

Gavrilov, L.A.; Gavrilova, N.S.; Kroutko, V.N.; Evdokushkina, G.N.; Semyonova, V.G.; Gavrilova, A.L.; Lapshin, E.V.; Evdokushkina, N.N.; Kushnareva, Y.E. 1997: Mutation load and human longevity. Mutation Research 377(1): 61-62

Kondrashov, A.S. 1994: Mutation load under vegetative reproduction and cytoplasmic inheritance. Genetics 137(1): 311-318

Koshi, J.M.; Goldstein, R.A. 1997: Mutation matrices and physical-chemical properties: Correlations and implications. Proteins 27(3): 336-344

Puck, T.T.; Johnson, R.; Webb, P.; Yohrling, G. 1998: Mutation measurement in mammalian cells. IV: Comparison of gamma-ray and chemical mutagenesis. Somatic Cell and Molecular Genetics 24(1): 1-11

Engeland, K.; Höög, J.O.; Holmquist, B.; Estonius, M.; Jörnvall, H.; Vallee, B.L. 1993: Mutation of Arg-115 of human class III alcohol dehydrogenase: a binding site required for formaldehyde dehydrogenase activity and fatty acid activation. Proceedings of the National Academy of Sciences of the United States of America 90(6): 2491-2494

Peng, G.; Ma, Z.; Kuai, L.; Zhu, D. 1997: Mutation of Arg154 to Gly154 in urokinase augments its fibrin-specificity. Biochemistry and Molecular Biology International 41(5): 887-894

Rosenfeld, R.D.; Noone, N.M.; Lauren, S.L.; Rohde, M.F.; Narhi, L.O.; Arakawa, T. 1993: Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I results in two forms different in disulfide structure and native conformation but similar under reverse-phase conditions. Journal of Protein Chemistry 12(3): 247-254

Zhang, R.; Fromm, H.J. 1995: Mutation of arginine 276 to methionine changes Mg2+ cooperativity and the kinetic mechanism of fructose-1,6-bisphosphatase. Biochemistry 34(25): 8190-8195

Groblewski, T.; Maigret, B.; Larguier, R.; Lombard, C.; Bonnafous, J.C.; Marie, J. 1997: Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation. Journal of Biological Chemistry 272(3): 1822-1826

Mirkov, T.E.; Chrispeels, M.J. 1993: Mutation of Asn128 to Asp of Phaseolus vulgaris leucoagglutinin (PHA-L) eliminates carbohydrate-binding and biological activity. Glycobiology 3(6): 581-587

Jagerschmidt, A.; Guillaume, N.; Goudreau, N.; Maigret, B.; Roques, B.P. 1995: Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Molecular Pharmacology 48(5): 783-789

Flemming, C.L.; Russell, S.J.; Collins, M.K. 1993: Mutation of Asp20 of human interleukin-2 reveals a dual role of the p55 alpha chain of the interleukin-2 receptor. European Journal of Immunology 23(4): 917-921

Bihoreau, C.; Monnot, C.; Davies, E.; Teutsch, B.; Bernstein, K.E.; Corvol, P.; Clauser, E. 1993: Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proceedings of the National Academy of Sciences of the United States of America 90(11): 5133-5137

Shen, H.M.; Peters, A.; Baron, B.; Zhu, X.; Storb, U. 1998: Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280(5370): 1750-1752

Yang, J.; Williams, J.A.; Yule, D.I.; Logsdon, C.D. 1995: Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization. Molecular Pharmacology 48(3): 477-485

Tsai, K.Y.; Hu, Y.; Macleod, K.F.; Crowley, D.; Yamasaki, L.; Jacks, T. 1998: Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Molecular Cell 2(3): 293-304

Chen, P.F.; Tsai, A.L.; Berka, V.; Wu, K.K. 1997: Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers. Journal of Biological Chemistry 272(10): 6114-6118

Knowles, M.A.; Williamson, M. 1993: Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Research 53(1): 133-139

Prapapanich, V.; Chen, S.; Smith, D.F. 1998: Mutation of Hip's carboxy-terminal region inhibits a transitional stage of progesterone receptor assembly. Molecular and Cellular Biology 18(2): 944-952

Russell, S.M.; Tayebi, N.; Nakajima, H.; Riedy, M.C.; Roberts, J.L.; Aman, M.J.; Migone, T.S.; Noguchi, M.; Markert, M.L.; Buckley, R.H.; O'Shea, J.J.; Leonard, W.J. 1995: Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 270(5237): 797-800

Mok, S.C.; Bell, D.A.; Knapp, R.C.; Fishbaugh, P.M.; Welch, W.R.; Muto, M.G.; Berkowitz, R.S.; Tsao, S.W. 1993: Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Research 53(7): 1489-1492

Ichikawa, Y.; Nishida, M.; Suzuki, H.; Yoshida, S.; Tsunoda, H.; Kubo, T.; Uchida, K.; Miwa, M. 1994: Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Research 54(1): 33-35

Lusti-Narasimhan, M.; Power, C.A.; Allet, B.; Alouani, S.; Bacon, K.B.; Mermod, J.J.; Proudfoot, A.E.; Wells, T.N. 1995: Mutation of Leu25 and Val27 introduces CC chemokine activity into interleukin-8. Journal of Biological Chemistry 270(6): 2716-2721

Polticelli, F.; Battistoni, A.; Bottaro, G.; Carrì, M.T.; O'Neill, P.; Desideri, A.; Rotilio, G. 1994: Mutation of Lys-120 and Lys-134 drastically reduces the catalytic rate of Cu,Zn superoxide dismutase. Febs Letters 352(1): 76-78

Sessa, W.C.; Barber, C.M.; Lynch, K.R. 1993: Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circulation Research 72(4): 921-924

Yu-Lunyin, L.-Mingqiu; Zou-Zuyu 1996: Mutation of P53 gene and cell proliferation in human lung cancer: An immunohistochemical study for P53 and proliferating cell nuclear antigen. Acta Academiae Medicinae Hubei 17(3): 201-204

Pérez, I.; Lin, C.H.; McAfee, J.G.; Patton, J.G. 1997: Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo. Rna 3(7): 764-778

Konopka, J.B.; Margarit, S.M.; Dube, P. 1996: Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. Proceedings of the National Academy of Sciences of the United States of America 93(13): 6764-6769

Boccia, L.M.; Green, J.S.; Joyce, C.; Eng, C.; Taylor, S.A.; Mulligan, L.M. 1997: Mutation of RET codon 768 is associated with the FMTC phenotype. Clinical Genetics 51(2): 81-85

Migita, M.; Hiromatsu, Y.; Sato, M.; Yang, D.; Kameo, J.; Jimi, A.; Nonaka, K. 1997: Mutation of RET proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Endocrine Journal 44(4): 559-565

Villard, J.; Lisowska-Grospierre, B.; van den Elsen, P.; Fischer, A.; Reith, W.; Mach, B. 1997: Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. New England Journal of Medicine 337(11): 748-753

Stevenson, B.J.; Ferguson, B.; De Virgilio, C.; Bi, E.; Pringle, J.R.; Ammerer, G.; Sprague, G.F. 1995: Mutation of RGA1, which encodes a putative GTPase-activating protein for the polarity-establishment protein Cdc42p, activates the pheromone-response pathway in the yeast Saccharomyces cerevisiae. Genes and Development 9(23): 2949-2963

Liu, L.N.; Dias, P.; Houghton, P.J. 1998: Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 9(9): 699-711

Thome, K.C.; Radfar, A.; Rosenberg, N. 1997: Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells. Journal of Virology 71(11): 8149-8156

Li, H.; Lu, S. 1995: Mutation of tumor suppressor genes APC and MCC in human esophageal cancer. Zhonghua Zhong Liu Za Zhi 17(1): 9-12

Diggle, C.; Quirk, P.G.; Bizouarn, T.; Grimley, R.I.; Cotton, N.P.; Thomas, C.M.; Jackson, J.B. 1996: Mutation of Tyr235 in the NAD(H)-binding subunit of the proton-translocating nicotinamide nucleotide transhydrogenase of Rhodospirillum rubrum affects the conformational dynamics of a mobile loop and lowers the catalytic activity of the enzyme. Journal of Biological Chemistry 271(17): 10109-10115

van der Geer, P.; Hunter, T. 1993: Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts. EMBO Journal 12(13): 5161-5172

Lawson, T.; Kolar, C. 1992: Mutation of V79 cells by n-dialkylnitrosamines after activation by hamster pancreas duct cells. Mutation Research 272(2): 139-144

Vijapurkar, U.; Cheng, K.; Koland, J.G. 1998: Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase. Journal of Biological Chemistry 273(33): 20996-21002

Hansen, K.; Johnell, M.; Siegbahn, A.; Rorsman, C.; Engström, U.; Wernstedt, C.; Heldin, C.H.; Rönnstrand, L. 1996: Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO Journal 15(19): 5299-5313

Kazmi, M.A.; Sakmar, T.P.; Ostrer, H. 1997: Mutation of a conserved cysteine in the X-linked cone opsins causes color vision deficiencies by disrupting protein folding and stability. IOVS Investigative Ophthalmology and Visual Science 38(6): 1074-1081

Yee, D., K.; Kisley, L., R.; Heerding, J., N.; Fluharty, S., J. 1997: Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor. Molecular Brain Research 51(1-2): 238-241

Geering, K.; Jaunin, P.; Jaisser, F.; Mérillat, A.M.; Horisberger, J.D.; Mathews, P.M.; Lemas, V.; Fambrough, D.M.; Rossier, B.C. 1993: Mutation of a conserved proline residue in the beta-subunit ectodomain prevents Na(+)-K(+)-ATPase oligomerization. American Journal of Physiology 265(4 Pt 1): C1169-C1174

Claude, P.A.; Wotta, D.R.; Zhang, X.H.; Prather, P.L.; Mcginn, T.M.; Erickson, L.J.; Loh, H.H.; Law, P.Y. 1996: Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proceedings of the National Academy of Sciences of the United States of America 93(12): 5715-5719

Glenn, G.M.; Eckhart, W. 1993: Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation. Journal of Virology 67(4): 1945-1952

Eudy, J.D.; Weston, M.D.; Yao, S.; Hoover, D.M.; Rehm, H.L.; Ma-Edmonds, M.; Yan, D.; Ahmad, I.; Cheng, J.J.; Ayuso, C.; Cremers, C.; Davenport, S.; Moller, C.; Talmadge, C.B.; Beisel, K.W.; Tamayo, M.; Morton, C.C.; Swaroop, A.; Kimberling, W.J.; Sumegi, J. 1998: Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 280(5370): 1753-1757

Zuther, E.; Schubert, H.; Hagemann, M. 1998: Mutation of a gene encoding a putative glycoprotease leads to reduced salt tolerance, altered pigmentation, and cyanophycin accumulation in the cyanobacterium Synechocystis sp. strain PCC 6803. Journal of Bacteriology 180(7): 1715-1722

Ohkura, H.; Török, T.; Tick, G.; Hoheisel, J.; Kiss, I.; Glover, D.M. 1997: Mutation of a gene for a Drosophila kinesin-like protein, Klp38B, leads to failure of cytokinesis. Journal of Cell Science 110: 945-954

Wang, Z.; Wang, H.; Ascoli, M. 1993: Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. Molecular Endocrinology 7(1): 85-93

Hall, M.C.; Matson, S.W. 1997: Mutation of a highly conserved arginine in motif IV of Escherichia coli DNA helicase II results in an ATP-binding defect. Journal of Biological Chemistry 272(30): 18614-18620

Tao, Q.; Abood, M.E. 1998: Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. Journal of Pharmacology and Experimental Therapeutics 285(2): 651-658

Weiss-Brummer, B.; Zollner, A.; Haid, A.; Thompson, S. 1995: Mutation of a highly conserved base in the yeast mitochondrial 21S rRNA restricts ribosomal frameshifting. Molecular and General Genetics: Mgg 248(2): 207-216

Gallagher, P.G.; Petruzzi, M.J.; Weed, S.A.; Zhang, Z.; Marchesi, S.L.; Mohandas, N.; Morrow, J.S.; Forget, B.G. 1997: Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia. Journal of Clinical Investigation 99(2): 267-277

Ross-Macdonald, P.; Roeder, G.S. 1994: Mutation of a meiosis-specific MutS homolog decreases crossing over but not mismatch correction. Cell 79(6): 1069-1080

Jackson, P.K.; Paskind, M.; Baltimore, D. 1993: Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene 8(7): 1943-1956

Oehler, T.; Pintzas, A.; Stumm, S.; Darling, A.; Gillespie, D.; Angel, P. 1993: Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun. Oncogene 8(5): 1141-1147

Ward, P.N.; Higgins, T.E.; Murphy, A.C.; Mullan, P.B.; Rozengurt, E.; Lax, A.J. 1994: Mutation of a putative ADP-ribosylation motif in the Pasteurella multocida toxin does not affect mitogenic activity. Febs Letters 342(1): 81-84

Carlson, S.A.; Chatterjee, T.K.; Murphy, K.P.; Fisher, R.A. 1998: Mutation of a putative amphipathic alpha-helix in the third intracellular domain of the platelet-activating factor receptor disrupts receptor/G protein coupling and signaling. Molecular Pharmacology 53(3): 451-458

Vermaas, W.; Vass, I.; Eggers, B.; Styring, S. 1994: Mutation of a putative ligand to the non-heme iron in photosystem II: Implications for Q-A reactivity, electron transfer, and herbicide binding. Biochimica et Biophysica Acta 1184(2-3): 263-272

Davidson, A.L.; Sharma, S. 1997: Mutation of a single MalK subunit severely impairs maltose transport activity in Escherichia coli. Journal of Bacteriology 179(17): 5458-5464

Tyler, J.K.; Allen, K.E.; Everett, R.D. 1994: Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein. Nucleic Acids Research 22(3): 270-278

Govindjee, R.; Imasheva, E.S.; Misra, S.; Balashov, S.P.; Ebrey, T.G.; Chen, N.; Menick, D.R.; Crouch, R.K. 1997: Mutation of a surface residue, lysine-129, reverses the order of proton release and uptake in bacteriorhodopsin; guanidine hydrochloride restores it. Biophysical Journal 72(2 Pt 1): 886-898

Canessa, C.M.; Horisberger, J.D.; Rossier, B.C. 1993: Mutation of a tyrosine in the H-3-H-4 ectodomain of sodium, potassium ATPase alpha subunit confers ouabain resistance. Journal of Biological Chemistry 268(24): 17722-17726

Wilcox, C.A.; Redding, K.; Wright, R.; Fuller, R.S. 1992: Mutation of a tyrosine localization signal in the cytosolic tail of yeast Kex2 protease disrupts Golgi retention and results in default transport to the vacuole. Molecular Biology of the Cell 3(12): 1353-1371

Nicoll, D.A.; Hryshko, L.V.; Matsuoka, S.; Frank, J.S.; Philipson, K.D. 1996: Mutation of amino acid residues in the putative transmembrane segments of the cardiac sarcolemmal Na+-Ca2+ exchanger. Journal of Biological Chemistry 271(23): 13385-13391

Stelter, F.; Bernheiden, M.; Menzel, R.; Jack, R.S.; Witt, S.; Fan, X.; Pfister, M.; Schütt, C. 1997: Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. European Journal of Biochemistry 243(1-2): 100-109

Tailor, C.S.; Takeuchi, Y.; O'Hara, B.; Johann, S.V.; Weiss, R.A.; Collins, M.K. 1993: Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. Journal of Virology 67(11): 6737-6741

Drayer, A.L.; Meima, M.E.; Derks, M.W.; Tuik, R.; van Haastert, P.J. 1995: Mutation of an EF-hand Ca(2+)-binding motif in phospholipase C of Dictyostelium discoideum: inhibition of activity but no effect on Ca(2+)-dependence. Biochemical Journal 311: 505-510

Gontarek, R.R.; McNally, M.T.; Beemon, K. 1993: Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes and Development 7(10): 1926-1936

Jhee, K.H.; Yang, L.H.; Ahmed, S.A.; McPhie, P.; Rowlett, R.; Miles, E.W. 1998: Mutation of an active site residue of tryptophan synthase (beta-serine 377) alters cofactor chemistry. Journal of Biological Chemistry 273(19): 11417-11422

Campbell, E.L.; Brahamsha, B.; Meeks, J.C. 1998: Mutation of an alternative sigma factor in the cyanobacterium Nostoc punctiforme results in increased infection of its symbiotic plant partner, Anthoceros punctatus. Journal of Bacteriology 180(18): 4938-4941

Kavanaugh, M.P.; Bendahan, A.; Zerangue, N.; Zhang, Y.; Kanner, B.I. 1997: Mutation of an amino acid residue influencing potassium coupling in the glutamate transporter GLT-1 induces obligate exchange. Journal of Biological Chemistry 272(3): 1703-1708

Parent, J.L.; Le Gouill, C.; Rola-Pleszczynski, M.; Stanková, J. 1996: Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production. Biochemical and Biophysical Research Communications 219(3): 968-975

Kong, H.; Raynor, K.; Yasuda, K.; Bell, G.I.; Reisine, T. 1993: Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. Molecular Pharmacology 44(2): 380-384

Faber, H.R.; Baker, C.J.; Day, C.L.; Tweedie, J.W.; Baker, E.N. 1996: Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutants. Biochemistry 35(46): 14473-14479

Misra, S.; Martin, C.; Kwon, O.H.; Ebrey, T.G.; Chen, N.; Crouch, R.K.; Menick, D.R. 1997: Mutation of arginine 134 to lysine alters the pKas of key groups involved in proton pumping by bacteriorhodopsin. Photochemistry and Photobiology 66(6): 774-783,.